Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Pharmacology for Nurses

Index

Pharmacology for NursesIndex
Symbols
“Do Not Use” list of abbreviations 3.3 Documentation and Informatics
17-beta-estradiol 37.2 Feminizing Hormonal Therapy
5-alpha-reductase inhibitors 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors, 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
5-Fluorouracil 8.2 Chemotherapeutic Drugs
A
A (Retinol and beta carotene) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Abilify 13.2 Antipsychotics
abortifacients 36.3 Uterine Motility Drugs and Lactation Considerations
Abortive therapy 12.2 Migraine Headaches and Migraine Headache Drugs
absence seizures 12.1 Epilepsy and Anticonvulsant Drugs
Absorption 2.2 Pharmacokinetics and Pharmacodynamics, 29.1 Introduction to the Gastrointestinal System and Oral Cavity
abuse deterrence 15.2 Opioid Use Disorder Drugs
Acarbose 28.3 Oral Antidiabetic Drugs, 28.3 Oral Antidiabetic Drugs
Accolate 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
accommodation 38.1 Introduction to the Eyes
Accuneb 25.1 Adrenergics and Anticholinergics
Accupril 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
ACE inhibitor 13.2 Antipsychotics
Acebutolol 17.1 Introduction to Dysrhythmias
Acetaminophen 14.2 Nonopioid Analgesics
acetazolamide 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Acetylcholine 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 9.3 Characteristics of Drugs to Treat Nervous System Disorders, Introduction, 25.1 Adrenergics and Anticholinergics
acetylcholinesterase inhibitor 13.4 Anxiolytics and Sedative-Hypnotics
Acetylcysteine 24.3 Expectorants and Mucolytics
ACh Introduction
AChE inhibitors 10.2 Cholinergic Drugs, 10.4 Alzheimer’s Drugs, 10.4 Alzheimer’s Drugs
Aciphex 10.4 Alzheimer’s Drugs
Acitretin 40.3 Psoriatic Drugs
Acne vulgaris 40.2 Acne Drugs
Acnecycline 40.2 Acne Drugs
acquired immunity 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
acquired immunodeficiency syndrome (AIDS) 7.3 Introduction to HIV, AIDS, and Antiretrovirals
acromegaly 26.2 Growth Hormones and Suppressants
ActHIB 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
action 2.2 Pharmacokinetics and Pharmacodynamics
action potential 16.3 Conduction of Electrical Impulses
Actiq 14.3 Opioid Agonists and Antagonists
Activase 20.4 Thrombolytics
Activated clotting time (ACT) 20.2 Anticoagulants
Active immunity 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
active transport 4.1 What Is Homeostasis?
Actonel 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Actos 28.3 Oral Antidiabetic Drugs
Acular 38.2 Ocular Anti-inflammatories and Anti-infectives
Acupuncture 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
acute angle-closure (narrow-angle) glaucoma 38.4 Antiglaucoma Drugs
acute kidney injury (AKI) 34.1 Introduction to Diuretics
acute myocardial infarction 22.1 Introduction to Cardiac Emergencies and Shock
Acute pain 14.1 Introduction to Pain
Acyclovir 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Adacel 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Adalimumab 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 40.3 Psoriatic Drugs
Adapalene 40.2 Acne Drugs
adaptive immune system 6.1 Introduction to Immunity
adaptive immunity 7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections
Adderall 13.5 CNS Stimulants and Nonstimulants, 13.5 CNS Stimulants and Nonstimulants
addiction 14.3 Opioid Agonists and Antagonists, 15.1 Introduction to Substance Use Disorders
Addison’s disease 26.4 Glucocorticoids and Mineralocorticoids
Adenocarcinomas 8.1 Introduction to Cancer and Phases of Cancer Therapy
Adenocard 17.6 Unclassified Antidysrhythmics
adenohypophysis 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
Adenosine 17.1 Introduction to Dysrhythmias, 17.6 Unclassified Antidysrhythmics, 22.2 Cardiac Emergency Drugs
adenosine 5-triphosphate (ATP) 4.3 Maintaining Homeostasis
Adenosine diphosphate 20.1 Introduction to Clotting and Coagulation
ADH 26.3 Antidiuretic Hormones
Adipex-P 32.2 Anorexiants
adipose 32.1 Introduction to Weight Management
Adjuvant therapy 8.2 Chemotherapeutic Drugs
Adlarity 10.4 Alzheimer’s Drugs
adolescents 13.1 Antidepressants, 15.4 Nicotine Use Disorder Drugs, 40.2 Acne Drugs
adrenal cortex 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
adrenal glands 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
adrenal insufficiency 25.2 Corticosteroids
Adrenalin 25.1 Adrenergics and Anticholinergics
adrenaline 22.2 Cardiac Emergency Drugs
Adrenergic 25.1 Adrenergics and Anticholinergics
adrenergic agonist 22.2 Cardiac Emergency Drugs
adrenergic receptors 9.3 Characteristics of Drugs to Treat Nervous System Disorders, Introduction
Adrenocorticotropic hormone (ACTH) 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
Adriamycin 8.2 Chemotherapeutic Drugs
adverse drug event 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice , 3.2 Drug Errors and Prevention, 3.3 Documentation and Informatics
adverse drug reaction 3.2 Drug Errors and Prevention
adverse drug reactions 2.2 Pharmacokinetics and Pharmacodynamics, 3.2 Drug Errors and Prevention
adverse effects 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
Advil 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 14.2 Nonopioid Analgesics
affective 13.1 Antidepressants
affective domain 2.1 Drug Administration and the Nursing Process
affinity 2.2 Pharmacokinetics and Pharmacodynamics, 10.2 Cholinergic Drugs
Affordable Care Act 1.4 Special Considerations, 3.1 Legal Considerations, 3.1 Legal Considerations
Afluria 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
African descent 28.1 Introduction to Diabetes
Afterload 16.2 Pumping Action of the Heart, 19.1 Heart Failure
Agency for Healthcare Research and Quality 3.3 Documentation and Informatics
agglutination 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
agonist 2.2 Pharmacokinetics and Pharmacodynamics, 26.2 Growth Hormones and Suppressants
agranulocytosis 31.2 Histamine Blockers and Proton-Pump Inhibitors
akathisia 11.1 Introduction to Parkinson’s Disease, 13.2 Antipsychotics
Alaska Native 28.1 Introduction to Diabetes
Albuterol 22.3 Shock Drugs, 25.1 Adrenergics and Anticholinergics
Alcaine 38.3 Ocular Anesthetics and Lubricants
Alcohol 15.3 Alcohol Use Disorder Drugs
Aldactone 18.6 Diuretics, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 34.4 Potassium-Sparing Diuretics
aldosterone 18.1 Hypertension and Angina
aldosterone antagonists 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Alemtuzumab 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Alendronate 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Alesse 36.2 Hormonal, Contraception, and Infertility Drugs
Aleve 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 14.2 Nonopioid Analgesics
Alfuzosin 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
alimentary canal 29.1 Introduction to the Gastrointestinal System and Oral Cavity
Alimta 8.2 Chemotherapeutic Drugs
Alinia 7.6 Antiparasitic and Anthelminthic Drugs
Alirocumab 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Alka-Seltzer 31.1 Antacids
Alkyl Sulfonates 8.2 Chemotherapeutic Drugs
Alkylating agents 8.2 Chemotherapeutic Drugs
Alkylating-Like Drugs 8.2 Chemotherapeutic Drugs
Allegra 8.2 Chemotherapeutic Drugs, 24.1 Antihistamines and Decongestants
allergic reaction 3.2 Drug Errors and Prevention, 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Alli 32.3 Lipase Inhibitors
Allopurinol 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 8.1 Introduction to Cancer and Phases of Cancer Therapy
alopecia 8.2 Chemotherapeutic Drugs, 31.2 Histamine Blockers and Proton-Pump Inhibitors
alpha blockers 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
alpha receptors 9.3 Characteristics of Drugs to Treat Nervous System Disorders
Alpha- and beta-adrenergic agonists 25.1 Adrenergics and Anticholinergics
alpha-1 receptor agonist 22.3 Shock Drugs
alpha-2 adrenergic agonist 13.4 Anxiolytics and Sedative-Hypnotics
alpha-adrenergic blockers 12.2 Migraine Headaches and Migraine Headache Drugs
Alpha-glucosidase inhibitors 28.3 Oral Antidiabetic Drugs
alpha-synuclein 11.1 Introduction to Parkinson’s Disease
Alphagan P 38.4 Antiglaucoma Drugs
Alprazolam 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics
Altabax 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Alteplase 20.4 Thrombolytics
Aluminum hydroxide 31.1 Antacids
Alzheimer’s disease (AD) 10.3 Introduction to Alzheimer’s Disease
Amantadine 11.2 Anti-Parkinsonian Drugs
Ambien 13.4 Anxiolytics and Sedative-Hypnotics
American Academy of Child and Adolescent Psychiatry 13.2 Antipsychotics
American Academy of Ophthalmology 38.1 Introduction to the Eyes
American College of Obstetricians and Gynecologists 36.2 Hormonal, Contraception, and Infertility Drugs
American Geriatrics Society 1.4 Special Considerations, 11.2 Anti-Parkinsonian Drugs
American Geriatrics Society Beers Criteria 11.2 Anti-Parkinsonian Drugs
American Heart Association 18.1 Hypertension and Angina, 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 22.1 Introduction to Cardiac Emergencies and Shock, 32.1 Introduction to Weight Management
American Indian 28.1 Introduction to Diabetes
American Lung Association 23.2 Introduction to the Lower Respiratory System
American Nurses Association (ANA) 3.2 Drug Errors and Prevention
American Psychiatric Association 13.1 Antidepressants
Ametop 38.3 Ocular Anesthetics and Lubricants
Amiloride 18.6 Diuretics, 34.4 Potassium-Sparing Diuretics
Amino acids 32.1 Introduction to Weight Management
aminoglycosides 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Aminophylline 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
amiodarone 11.2 Anti-Parkinsonian Drugs , 17.1 Introduction to Dysrhythmias, 17.4 Class III: Potassium Channel Blockers, 22.2 Cardiac Emergency Drugs
Amlodipine 18.5 Calcium Channel Blockers
Amoxicillin 39.2 Otic Anti-inflammatories and Anti-infectives
Amoxicillin-clavulanate 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 39.2 Otic Anti-inflammatories and Anti-infectives
Amoxil 39.2 Otic Anti-inflammatories and Anti-infectives
Amphetamine and dextroamphetamine 13.5 CNS Stimulants and Nonstimulants
Amphojel 31.1 Antacids
amylase 29.3 Introduction to the Small and Large Intestines
Amylin Analogs 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
ANA Code of Ethics 3.2 Drug Errors and Prevention
Anabolic steroids 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Anaphylactic shock 22.3 Shock Drugs
anaphylaxis 3.2 Drug Errors and Prevention, 22.1 Introduction to Cardiac Emergencies and Shock
Anastrozole 8.3 Hormonal Therapy
Ancoban 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Androderm 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Androgens 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus, 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Andropause 36.5 Review of the Male Reproductive System
Angina 18.1 Hypertension and Angina, 22.1 Introduction to Cardiac Emergencies and Shock
angioedema 13.4 Anxiolytics and Sedative-Hypnotics, 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Angiomax 20.2 Anticoagulants
angiotensin I 18.1 Hypertension and Angina
angiotensin II 18.1 Hypertension and Angina
Angiotensin II receptor blockers (ARBs) 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
angiotensin receptor/neprilysin inhibitors (ARNIs) 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Angiotensin-converting enzyme (ACE) inhibitors 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Anhidrosis 11.2 Anti-Parkinsonian Drugs
Anidulafungin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 39.1 Introduction to the Ears
anions 4.1 What Is Homeostasis?
Anorexiants 32.2 Anorexiants
Antabuse 15.3 Alcohol Use Disorder Drugs
Antacids 29.3 Introduction to the Small and Large Intestines, 31.1 Antacids
antagonist 2.2 Pharmacokinetics and Pharmacodynamics
anterograde amnesia 13.4 Anxiolytics and Sedative-Hypnotics
anthelminthic agents 7.6 Antiparasitic and Anthelminthic Drugs
Anthracyclines/Antitumor Antibiotics 8.2 Chemotherapeutic Drugs
Anti-factor Xa level (Anti-Xa) 20.2 Anticoagulants
anti-infective stewardship 7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections
anti-infectives 35.1 Urinary Anti-infectives
anti-inflammatory 13.2 Antipsychotics
Anti-inflammatory drugs 39.2 Otic Anti-inflammatories and Anti-infectives
Antiandrogens 8.3 Hormonal Therapy, 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Antianginal drugs Introduction
antiarrhythmic 11.2 Anti-Parkinsonian Drugs , 22.2 Cardiac Emergency Drugs
antibiogram 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Antibiotic drug resistance 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
antibiotics 23.2 Introduction to the Lower Respiratory System, 29.3 Introduction to the Small and Large Intestines
Antibodies 6.1 Introduction to Immunity
Antibody mediated/humoral immunity 6.1 Introduction to Immunity
anticholinergic 22.2 Cardiac Emergency Drugs
Anticholinergic drugs 25.1 Adrenergics and Anticholinergics
anticholinergic effects 30.2 Antidiarrheals
Anticholinergics 11.2 Anti-Parkinsonian Drugs , 30.1 Antiemetics, 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Anticoagulant Reversal Agents 20.2 Anticoagulants
Anticoagulants 20.2 Anticoagulants
anticonvulsant drugs 12.1 Epilepsy and Anticonvulsant Drugs
antidepressant 32.4 Other Drugs, Supplements, and Herbal Remedies
antidepressant responses in populations of color 13.1 Antidepressants
antidiabetic 11.2 Anti-Parkinsonian Drugs
Antidiarrheal 29.3 Introduction to the Small and Large Intestines, 30.2 Antidiarrheals
Antidiuretic hormone 16.1 Introduction to the Heart, Circulation, and Blood Flow, 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus, 34.1 Introduction to Diuretics
antidysrhythmic drugs 17.2 Class I: Sodium Channel Blockers
Antiemetics 29.3 Introduction to the Small and Large Intestines, 30.1 Antiemetics
Antiestrogens 8.3 Hormonal Therapy
antifungal drugs 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Antigen-antibody interactions 6.1 Introduction to Immunity
Antigout drugs 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Antihistamines 8.2 Chemotherapeutic Drugs, 24.1 Antihistamines and Decongestants, 24.1 Antihistamines and Decongestants, 30.1 Antiemetics, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
antihistamines for ear disorders 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Antihypertensive drugs Introduction
Antimalarial drugs 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Antimetabolites 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Antimicrobials 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
antimuscarinics 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
antiparasitic drugs 7.6 Antiparasitic and Anthelminthic Drugs
antipsychotic 11.2 Anti-Parkinsonian Drugs , 13.2 Antipsychotics, 13.4 Anxiolytics and Sedative-Hypnotics, 13.5 CNS Stimulants and Nonstimulants
antipyretics 14.2 Nonopioid Analgesics
Antiretroviral Drugs 7.3 Introduction to HIV, AIDS, and Antiretrovirals
antiretroviral therapy (ART) 7.3 Introduction to HIV, AIDS, and Antiretrovirals
antisecretory 31.2 Histamine Blockers and Proton-Pump Inhibitors
antiseizure medications 13.3 Mood Stabilizers
antispasmodics 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Antithyroid drugs 27.2 Thyroid and Antithyroid Drugs
antitubercular drugs 7.5 Introduction to Tuberculosis and Antitubercular Drugs
Antitussives 24.2 Antitussives
Antivert 30.1 Antiemetics
antiviral drugs 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Anxiety 13.4 Anxiolytics and Sedative-Hypnotics, 38.1 Introduction to the Eyes
Anxiolytics 13.4 Anxiolytics and Sedative-Hypnotics
Apidra 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Apixaban 20.2 Anticoagulants
Apokyn 11.2 Anti-Parkinsonian Drugs
Apomorphine hydrochloride 11.2 Anti-Parkinsonian Drugs
apoptosis 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 10.3 Introduction to Alzheimer’s Disease
apothecary system 2.4 Dosage Calculations
Aprepitant 30.1 Antiemetics
Apri 28 36.2 Hormonal, Contraception, and Infertility Drugs
aqueous humor 38.1 Introduction to the Eyes
Ara-C 8.2 Chemotherapeutic Drugs
Argatroban 20.2 Anticoagulants
Aricept 10.4 Alzheimer’s Drugs, 10.4 Alzheimer’s Drugs
Arimadex 8.3 Hormonal Therapy
Aripiprazole 13.2 Antipsychotics, 13.2 Antipsychotics
Arlex 30.3 Laxatives and Stool Softeners
Aromasin 8.3 Hormonal Therapy
Aromatase Inhibitors 8.3 Hormonal Therapy
Aromatherapy 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
arrhythmias 16.3 Conduction of Electrical Impulses, 17.1 Introduction to Dysrhythmias, 17.1 Introduction to Dysrhythmias
Artane 11.2 Anti-Parkinsonian Drugs
arteries 16.1 Introduction to the Heart, Circulation, and Blood Flow
arthralgia 31.2 Histamine Blockers and Proton-Pump Inhibitors
Artificial tears 38.3 Ocular Anesthetics and Lubricants
ascites 34.2 Loop Diuretics
Asian American 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies, 28.1 Introduction to Diabetes
Asian clients 1.4 Special Considerations, 13.1 Antidepressants, 38.1 Introduction to the Eyes
Asian people 15.3 Alcohol Use Disorder Drugs, 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
asociality 13.2 Antipsychotics
aspiration 29.2 Introduction to the Esophagus and Stomach
Aspirin 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 14.2 Nonopioid Analgesics, 20.3 Antiplatelets, 22.2 Cardiac Emergency Drugs
Assessment 2.1 Drug Administration and the Nursing Process
asthenia 35.1 Urinary Anti-infectives
Asthma 23.2 Introduction to the Lower Respiratory System, Introduction
Astigmatism 38.1 Introduction to the Eyes
Astragalus 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
asystole 17.1 Introduction to Dysrhythmias, 22.2 Cardiac Emergency Drugs
Atacand 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
ataxia 11.3 Introduction to Multiple Sclerosis
Atazanavir 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Atenolol 17.1 Introduction to Dysrhythmias, 17.3 Class II: Beta Adrenergic Blockers, 18.4 Beta-Adrenergic Blockers
Atezolizumab 8.4 Biologic Response Modifiers
atherosclerosis 21.1 Introduction to Lipoprotein and Apolipoproteins
Ativan 12.1 Epilepsy and Anticonvulsant Drugs , 13.4 Anxiolytics and Sedative-Hypnotics, 15.3 Alcohol Use Disorder Drugs
Atomoxetine 13.5 CNS Stimulants and Nonstimulants
Atopic dermatitis 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Atorvastatin 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Atralin 40.2 Acne Drugs
atria 16.1 Introduction to the Heart, Circulation, and Blood Flow
atrial fibrillation with rapid ventricular response 17.1 Introduction to Dysrhythmias, 22.2 Cardiac Emergency Drugs
Atrial flutter 17.1 Introduction to Dysrhythmias
atrial natriuretic peptide 33.1 Introduction to the Renal System, 34.1 Introduction to Diuretics
AtroPen 17.6 Unclassified Antidysrhythmics
atrophy 11.1 Introduction to Parkinson’s Disease
Atropine 17.1 Introduction to Dysrhythmias, 17.6 Unclassified Antidysrhythmics, 22.2 Cardiac Emergency Drugs
Atrovent 25.1 Adrenergics and Anticholinergics
Attention deficit hyperactivity disorder 13.5 CNS Stimulants and Nonstimulants
atypical antipsychotics 13.2 Antipsychotics
Aubagio 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Augmentin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 39.2 Otic Anti-inflammatories and Anti-infectives
aura 12.2 Migraine Headaches and Migraine Headache Drugs
autoantibodies 10.1 Introduction to Myasthenia Gravis
autoimmune 11.3 Introduction to Multiple Sclerosis
autoimmune disorders 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
automaticity 16.3 Conduction of Electrical Impulses
Autonomy 3.2 Drug Errors and Prevention
Auvi-Q 25.1 Adrenergics and Anticholinergics
Avanafil 36.7 Phosphodiesterase 5 Inhibitors
Avastin 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Aviane 36.2 Hormonal, Contraception, and Infertility Drugs
Avodart 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
avolition 13.2 Antipsychotics
Avonex 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Axid 31.2 Histamine Blockers and Proton-Pump Inhibitors
Aygestin 36.2 Hormonal, Contraception, and Infertility Drugs
Ayurveda 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Azathioprine 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Azelaic acid 40.2 Acne Drugs
Azelex 40.2 Acne Drugs
Azilect 11.2 Anti-Parkinsonian Drugs
Azithromycin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 39.2 Otic Anti-inflammatories and Anti-infectives
Azoles 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Azopt 38.4 Antiglaucoma Drugs
Azstarys 13.5 CNS Stimulants and Nonstimulants
Azulfidine 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
B
B lymphocytes 11.3 Introduction to Multiple Sclerosis
B1 (Thiamine) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
B12 (Cobalamin) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
B2 (Riboflavin) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
B3 (Niacin) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
B9 (Folic acid) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Baclofen 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Bacterial vaginosis 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
bactericidal 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
bacteriostatic 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Bactrim 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 35.1 Urinary Anti-infectives
Bactroban 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Bafiertam 11.4 Drugs Used in the Treatment of Multiple Sclerosis
ballismus 11.2 Anti-Parkinsonian Drugs
Barbiturates 12.1 Epilepsy and Anticonvulsant Drugs , 12.1 Epilepsy and Anticonvulsant Drugs
Baroreceptor reflex 16.1 Introduction to the Heart, Circulation, and Blood Flow
Barotrauma 39.1 Introduction to the Ears
barriers to learning 2.1 Drug Administration and the Nursing Process
basal insulin dosing 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
basal metabolic rate (BMR) 32.1 Introduction to Weight Management
basic formula method 2.4 Dosage Calculations
BCNU 8.2 Chemotherapeutic Drugs
Beclomethasone 25.2 Corticosteroids
Beclovent 25.2 Corticosteroids
Beers Criteria 13.2 Antipsychotics, 35.1 Urinary Anti-infectives
Belsomra 13.4 Anxiolytics and Sedative-Hypnotics
Bempedoic acid 21.1 Introduction to Lipoprotein and Apolipoproteins
Benadryl 8.2 Chemotherapeutic Drugs, 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Benazepril 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors
Beneficence 3.2 Drug Errors and Prevention
benign Introduction
Benign paroxysmal positional vertigo (BPPV) 39.1 Introduction to the Ears
benign prostatic hyperplasia (BPH) 35.5 Phosphodiesterase 5 Inhibitors
Benzac 40.2 Acne Drugs
Benzathine penicillin G 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
benzodiazepine sedative-hypnotic 13.2 Antipsychotics
Benzodiazepines 12.1 Epilepsy and Anticonvulsant Drugs , 12.1 Epilepsy and Anticonvulsant Drugs , 13.4 Anxiolytics and Sedative-Hypnotics, 15.3 Alcohol Use Disorder Drugs
Benzonatate 24.2 Antitussives
benzothiadiazine 28.3 Oral Antidiabetic Drugs
Benzoyl peroxide 40.2 Acne Drugs
Benzphetamine 32.2 Anorexiants
Benztropine mesylate 11.2 Anti-Parkinsonian Drugs
beta blocker 13.5 CNS Stimulants and Nonstimulants, 17.3 Class II: Beta Adrenergic Blockers, 19.3 Beta-Adrenergic Blockers
beta receptors 9.3 Characteristics of Drugs to Treat Nervous System Disorders
beta-1 adrenergic agonist 22.2 Cardiac Emergency Drugs
beta-1 receptor agonist 22.3 Shock Drugs
beta-2 adrenergic agonist 25.1 Adrenergics and Anticholinergics
Beta-adrenergic 25.1 Adrenergics and Anticholinergics
beta-adrenergic blockers 2.2 Pharmacokinetics and Pharmacodynamics, 17.1 Introduction to Dysrhythmias, 17.3 Class II: Beta Adrenergic Blockers, 18.4 Beta-Adrenergic Blockers, 19.3 Beta-Adrenergic Blockers, 38.4 Antiglaucoma Drugs
Beta-lactamase inhibitors 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Betaject 26.4 Glucocorticoids and Mineralocorticoids
Betamethasone 26.4 Glucocorticoids and Mineralocorticoids
Betapace 17.4 Class III: Potassium Channel Blockers
Betapace AF 17.4 Class III: Potassium Channel Blockers
Betaseron 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Betaxolol 17.1 Introduction to Dysrhythmias
Betaxolol hydrochloride 38.4 Antiglaucoma Drugs
Bethanechol chloride 35.4 Urinary Stimulants
Betoptic 38.4 Antiglaucoma Drugs
Bevacizumab 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Bexsero 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Bicalutamide 8.3 Hormonal Therapy, 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Bicillin L-A 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
BiDil 19.6 Adjunct Medications Used in Heart Failure
bile 29.1 Introduction to the Gastrointestinal System and Oral Cavity
Bile acid sequestrants 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Bimatoprost 0.01% and 0.03% solution 38.4 Antiglaucoma Drugs
Bioavailability 2.2 Pharmacokinetics and Pharmacodynamics
Biologic DMARDs 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Biologic drugs 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
biologic psoriatic drugs 40.3 Psoriatic Drugs
Biologic Response Modifiers 8.4 Biologic Response Modifiers
Biologic therapy 8.2 Chemotherapeutic Drugs
biologics 1.2 Drug Sources, Forms, and Names, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Biosimilar drugs 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Biosimilars 1.2 Drug Sources, Forms, and Names
Biphasic COCs 36.2 Hormonal, Contraception, and Infertility Drugs
bipolar disorder 13.1 Antidepressants
Bisacodyl Pr 30.3 Laxatives and Stool Softeners
Bismuth subsalicylate 30.2 Antidiarrheals
Bisoprolol 17.1 Introduction to Dysrhythmias, 17.3 Class II: Beta Adrenergic Blockers, 19.3 Beta-Adrenergic Blockers
Bisphosphonates 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Bivalirudin 20.2 Anticoagulants
Black 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 28.1 Introduction to Diabetes, 28.1 Introduction to Diabetes, 32.1 Introduction to Weight Management, 38.1 Introduction to the Eyes
Black adults 16.1 Introduction to the Heart, Circulation, and Blood Flow, 18.5 Calcium Channel Blockers
Black clients 1.4 Special Considerations, 11.3 Introduction to Multiple Sclerosis, 13.1 Antidepressants, 14.1 Introduction to Pain, 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors, 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 19.6 Adjunct Medications Used in Heart Failure
bladder pain syndrome 35.3 Urinary Analgesics
Blenoxane 8.2 Chemotherapeutic Drugs
Bleomycin 8.2 Chemotherapeutic Drugs
Blood 5.1 Fluid Volume
Blood clotting 4.4 Negative Feedback Loop
blood dyscrasias 35.1 Urinary Anti-infectives
blood fractionation 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Blood products 5.1 Fluid Volume
blood urea nitrogen (BUN) 33.2 Renal-Associated Fluid Volume Excess, 34.1 Introduction to Diuretics
Bloxiverz 10.2 Cholinergic Drugs
board of nursing (BON) 3.1 Legal Considerations
Body mass index 32.1 Introduction to Weight Management
body surface area 2.4 Dosage Calculations
body surface area (BSA) method 2.4 Dosage Calculations
Body weight 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
body weight method 2.4 Dosage Calculations
bolus 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
bone marrow stimulant 13.4 Anxiolytics and Sedative-Hypnotics
Boniva 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Bortezomib 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Bowman’s capsule 33.1 Introduction to the Renal System
Bowman’s capsule hydrostatic pressure 33.1 Introduction to the Renal System
bradycardia 16.3 Conduction of Electrical Impulses, 17.1 Introduction to Dysrhythmias
Bradykinesia 11.1 Introduction to Parkinson’s Disease
brain herniation 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
brand name 1.2 Drug Sources, Forms, and Names
BRCA1 8.1 Introduction to Cancer and Phases of Cancer Therapy
BRCA2 8.1 Introduction to Cancer and Phases of Cancer Therapy
breastfeeding 36.3 Uterine Motility Drugs and Lactation Considerations
Brevibloc 17.3 Class II: Beta Adrenergic Blockers
Brilinta 20.3 Antiplatelets
Brimonidine 38.4 Antiglaucoma Drugs
Brinzolamide 1% solution 38.4 Antiglaucoma Drugs
Bromocriptine mesylate 11.2 Anti-Parkinsonian Drugs , 26.2 Growth Hormones and Suppressants
Brompheniramine 24.1 Antihistamines and Decongestants
bronchodilators 23.2 Introduction to the Lower Respiratory System
Budesonide 25.2 Corticosteroids
Bulk-forming 30.3 Laxatives and Stool Softeners
Bumetanide 19.5 Diuretics, 34.2 Loop Diuretics
Bumex 19.5 Diuretics, 34.2 Loop Diuretics
bundle of His 16.3 Conduction of Electrical Impulses
Buprenex 15.2 Opioid Use Disorder Drugs
Buprenorphine 15.2 Opioid Use Disorder Drugs
Buprenorphine-naltrexone 15.2 Opioid Use Disorder Drugs
Bupropion 15.4 Nicotine Use Disorder Drugs
Bupropion naltrexone 32.4 Other Drugs, Supplements, and Herbal Remedies
burns 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Busulfan 8.2 Chemotherapeutic Drugs
Busulfex 8.2 Chemotherapeutic Drugs
C
C (Ascorbic acid) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
CaCl 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
CaCl2 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Cafergot 12.2 Migraine Headaches and Migraine Headache Drugs
Calamine lotion 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Calan SR 17.5 Class IV: Calcium Channel Blockers, 18.5 Calcium Channel Blockers
Calananz 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
calcimimetics 27.1 Introduction to the Thyroid and Parathyroid, 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Calcipotriene 40.3 Psoriatic Drugs
calcitonin 27.1 Introduction to the Thyroid and Parathyroid
Calcitonin gene related peptide (CGRP) receptor antagonists 12.2 Migraine Headaches and Migraine Headache Drugs
calcitonin salmon 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
calcitriol 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Calcium (Ca) 5.2 Electrolytes
calcium absorption 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Calcium acetate 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Calcium carbonate 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 31.1 Antacids
Calcium channel blocker 13.4 Anxiolytics and Sedative-Hypnotics, 17.1 Introduction to Dysrhythmias, 17.5 Class IV: Calcium Channel Blockers, 18.5 Calcium Channel Blockers, 22.2 Cardiac Emergency Drugs
Calcium chloride 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
calcium citrate 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
calcium drugs 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Calcium gluconate 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Calcium polycarbophil 30.3 Laxatives and Stool Softeners
Calcium supplements 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Camila 36.2 Hormonal, Contraception, and Infertility Drugs
Canada’s drug laws 1.2 Drug Sources, Forms, and Names
Canadian Food and Drugs Act 1.2 Drug Sources, Forms, and Names
canaloplasty 38.1 Introduction to the Eyes
cancer 8.1 Introduction to Cancer and Phases of Cancer Therapy
Cancidas 39.1 Introduction to the Ears
Candesartan 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Candida auris 39.1 Introduction to the Ears
candidiasis 25.2 Corticosteroids
Cangrelor 20.3 Antiplatelets
Cannabinoids 30.1 Antiemetics
Cannabis (marijuana) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Cantharidin 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Capecitabine 8.2 Chemotherapeutic Drugs
capillaries 16.1 Introduction to the Heart, Circulation, and Blood Flow
Caplyta 13.3 Mood Stabilizers
Capto 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Captopril 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
carbamazepine 12.1 Epilepsy and Anticonvulsant Drugs , 13.3 Mood Stabilizers
carbamide peroxide 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
carbidopa 11.2 Anti-Parkinsonian Drugs
Carbidopa/levodopa extended release 11.2 Anti-Parkinsonian Drugs
Carbidopa/levodopa immediate-release tablet 11.2 Anti-Parkinsonian Drugs
Carbidopa/levodopa oral disintegrating tablet 11.2 Anti-Parkinsonian Drugs
carbohydrates 28.1 Introduction to Diabetes
Carbonic Anhydrase Inhibitors (CAIs) 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Carboplatin 8.2 Chemotherapeutic Drugs
Carboprost 36.3 Uterine Motility Drugs and Lactation Considerations
Cardene 18.5 Calcium Channel Blockers
cardiac cycle 16.2 Pumping Action of the Heart
Cardiac emergencies Introduction
Cardiac glycosides 19.6 Adjunct Medications Used in Heart Failure
cardiac output 16.1 Introduction to the Heart, Circulation, and Blood Flow, 18.1 Hypertension and Angina, 19.1 Heart Failure, 22.1 Introduction to Cardiac Emergencies and Shock
Cardiogenic shock 22.1 Introduction to Cardiac Emergencies and Shock, 22.1 Introduction to Cardiac Emergencies and Shock, 22.3 Shock Drugs
cardiotoxicity 13.1 Antidepressants
Cardiovascular diseases Introduction
cardioversion 17.1 Introduction to Dysrhythmias
Cardizem 17.5 Class IV: Calcium Channel Blockers, 18.5 Calcium Channel Blockers
Cardura 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Cariprazine 13.2 Antipsychotics
Carmustine 8.2 Chemotherapeutic Drugs
Carteolol hydrochloride 38.4 Antiglaucoma Drugs
Cartia XT 17.5 Class IV: Calcium Channel Blockers
Carvedilol 18.4 Beta-Adrenergic Blockers, 19.3 Beta-Adrenergic Blockers
Casodex 8.3 Hormonal Therapy
caspofungin 39.1 Introduction to the Ears
Castor oil 30.3 Laxatives and Stool Softeners
Cataplexy 13.5 CNS Stimulants and Nonstimulants
cataracts 38.1 Introduction to the Eyes
catatonia 13.2 Antipsychotics
catecholamine 11.2 Anti-Parkinsonian Drugs
Catecholomethyltransferase (COMT) Inhibitors 11.2 Anti-Parkinsonian Drugs
Cathflo Activase 20.4 Thrombolytics
cations 4.1 What Is Homeostasis?
CCNU 8.2 Chemotherapeutic Drugs
Cefdinir 39.2 Otic Anti-inflammatories and Anti-infectives
Ceftriaxone 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Celebrex 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 13.1 Antidepressants
Celecoxib 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Celestone 26.4 Glucocorticoids and Mineralocorticoids
Celexa 13.1 Antidepressants, 13.1 Antidepressants
cell-cycle nonspecific (CCNS) 8.2 Chemotherapeutic Drugs
cell-cycle specific agents (CCS) 8.2 Chemotherapeutic Drugs
Cell-mediated immunity 6.1 Introduction to Immunity
Cellcept 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Center for Drug Evaluation and Research (CDER) 1.2 Drug Sources, Forms, and Names
central nervous system (CNS) 9.2 Structure and Function of the Nervous System
Cephalexin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Cephalosporins 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
cerebral edema 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
cerebrospinal fluid 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Certificate of Vaccination 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Cerubidine 8.2 Chemotherapeutic Drugs
cerumenolytic 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Cervarix 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Cetamide 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
cetirizine 13.1 Antidepressants, 24.1 Antihistamines and Decongestants
Cetirizine hydrochloride 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Cetrorelix acetate 36.2 Hormonal, Contraception, and Infertility Drugs
Cetrotide 36.2 Hormonal, Contraception, and Infertility Drugs
chalazion 38.1 Introduction to the Eyes
Chamomile 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Chantix 15.4 Nicotine Use Disorder Drugs
charting 3.3 Documentation and Informatics
Chemical names 1.2 Drug Sources, Forms, and Names
Chemokine Coreceptor (CCR5) Antagonists 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Chemokines 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
chemoreceptor trigger zone (CTZ) 30.1 Antiemetics
chemotherapy 8.2 Chemotherapeutic Drugs
chemotherapy administration 8.2 Chemotherapeutic Drugs
children 1.2 Drug Sources, Forms, and Names, 4.1 What Is Homeostasis?, 13.1 Antidepressants, 13.1 Antidepressants, 13.4 Anxiolytics and Sedative-Hypnotics, 14.3 Opioid Agonists and Antagonists, 15.2 Opioid Use Disorder Drugs, 15.4 Nicotine Use Disorder Drugs, 24.1 Antihistamines and Decongestants, 24.1 Antihistamines and Decongestants, Introduction, 39.1 Introduction to the Ears, 39.1 Introduction to the Ears, 39.2 Otic Anti-inflammatories and Anti-infectives
children and adolescents 13.2 Antipsychotics, 18.1 Hypertension and Angina, 32.1 Introduction to Weight Management
Chlamydia 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Chlor-Trimeton 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Chlorambucil 8.2 Chemotherapeutic Drugs
chlordiazepoxide 13.2 Antipsychotics, 15.3 Alcohol Use Disorder Drugs
Chloride (Cl) 5.2 Electrolytes
Chloroquine 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Chloroquine FNA 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Chlorothiazide 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
Chlorpheniramine 24.1 Antihistamines and Decongestants
Chlorpheniramine maleate 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Chlorpromazine 13.2 Antipsychotics, 13.2 Antipsychotics, 30.1 Antiemetics
chlorpropamide 13.2 Antipsychotics
Chlorthalidone 18.6 Diuretics, 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
cholelithiasis 32.1 Introduction to Weight Management
Cholesevelam 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Cholesterol 21.1 Introduction to Lipoprotein and Apolipoproteins
cholesterol absorption inhibitors 21.4 Cholesterol Absorption Inhibitors
cholesterol management 21.1 Introduction to Lipoprotein and Apolipoproteins
Cholestyramine 21.3 Bile Acid Sequestrants, Fibrates, and Niacin, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Cholinergic agonists 10.2 Cholinergic Drugs
cholinergic blockers 11.2 Anti-Parkinsonian Drugs
cholinergic nerves 9.3 Characteristics of Drugs to Treat Nervous System Disorders
cholinergic receptors Introduction
choreoathetosis 11.2 Anti-Parkinsonian Drugs
Chromium picolinate 32.1 Introduction to Weight Management, 32.4 Other Drugs, Supplements, and Herbal Remedies
Chronic bronchitis 23.2 Introduction to the Lower Respiratory System
Chronic obstructive pulmonary disease (COPD) 23.2 Introduction to the Lower Respiratory System, Introduction
Chronic pain 14.1 Introduction to Pain
Chronic renal disease Introduction, 34.1 Introduction to Diuretics
chronotropic 10.4 Alzheimer’s Drugs
Chvostek sign 27.1 Introduction to the Thyroid and Parathyroid
Chylomicrons 21.1 Introduction to Lipoprotein and Apolipoproteins
chyme 29.1 Introduction to the Gastrointestinal System and Oral Cavity
Cialis 35.5 Phosphodiesterase 5 Inhibitors, 36.7 Phosphodiesterase 5 Inhibitors
Ciloxan 38.2 Ocular Anti-inflammatories and Anti-infectives
Cimetidine 31.2 Histamine Blockers and Proton-Pump Inhibitors
Cinacalcet 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Cinvanti 30.1 Antiemetics
Cipro HC 39.2 Otic Anti-inflammatories and Anti-infectives
Ciprodex 39.2 Otic Anti-inflammatories and Anti-infectives
Ciprofloxacin 0.2%
and hydrocortisone 1% 39.2 Otic Anti-inflammatories and Anti-infectives
Ciprofloxacin 0.3%
and dexamethasone 0.1% 39.2 Otic Anti-inflammatories and Anti-infectives
Ciprofloxacin
hydrochloride 0.3% 38.2 Ocular Anti-inflammatories and Anti-infectives
circadian rhythm 32.1 Introduction to Weight Management
Cisgender 37.1 Overview of Transgender and Nonbinary Health
Cisplatin 8.2 Chemotherapeutic Drugs
Citalopram 13.1 Antidepressants
Citroma 30.3 Laxatives and Stool Softeners
Citrucil 30.3 Laxatives and Stool Softeners
Clarinex 24.1 Antihistamines and Decongestants
Claritin 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Class I: Sodium channel blockers 17.1 Introduction to Dysrhythmias
class Ia antiarrhythmic 22.2 Cardiac Emergency Drugs
Class II: Beta-adrenergic blockers 17.1 Introduction to Dysrhythmias
class III antiarrhythmic 22.2 Cardiac Emergency Drugs
Class III: Potassium channel blockers 17.1 Introduction to Dysrhythmias
class IV antiarrhythmic 22.2 Cardiac Emergency Drugs
Class IV: Calcium channel blocker 17.1 Introduction to Dysrhythmias
class V antidysrhythmic 22.2 Cardiac Emergency Drugs
Clean eating 32.1 Introduction to Weight Management
Cleocin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them, 40.2 Acne Drugs
client education 2.1 Drug Administration and the Nursing Process
clients with darker skin 40.1 Introduction to the Skin and Its Function
Clindamycin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them, 40.2 Acne Drugs
Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) 15.3 Alcohol Use Disorder Drugs
Clinical judgment 2.1 Drug Administration and the Nursing Process
ClobaDerm 40.3 Psoriatic Drugs
Clobetasol 40.3 Psoriatic Drugs
Clomid 36.2 Hormonal, Contraception, and Infertility Drugs
Clomiphene 36.2 Hormonal, Contraception, and Infertility Drugs
Clonazepam 12.1 Epilepsy and Anticonvulsant Drugs , 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics
clonidine 13.4 Anxiolytics and Sedative-Hypnotics, 13.5 CNS Stimulants and Nonstimulants
Clopidogrel 20.3 Antiplatelets
Clorazepate 12.1 Epilepsy and Anticonvulsant Drugs
Closed-angle glaucoma 38.1 Introduction to the Eyes
clotting factors 20.1 Introduction to Clotting and Coagulation
Clozapine 13.2 Antipsychotics, 13.4 Anxiolytics and Sedative-Hypnotics
Clozaril 13.2 Antipsychotics, 13.2 Antipsychotics
CNS nonstimulant 13.4 Anxiolytics and Sedative-Hypnotics, 13.5 CNS Stimulants and Nonstimulants
CNS stimulants 13.5 CNS Stimulants and Nonstimulants
coagulation cascade 20.1 Introduction to Clotting and Coagulation
Coal tar lotion 40.3 Psoriatic Drugs
Coal tar shampoo 40.3 Psoriatic Drugs
Cobicistat 7.3 Introduction to HIV, AIDS, and Antiretrovirals
cochlear nerve 39.1 Introduction to the Ears
Codeine 14.3 Opioid Agonists and Antagonists
Cogentin 11.2 Anti-Parkinsonian Drugs
cognitive behavioral therapy 13.5 CNS Stimulants and Nonstimulants, 15.1 Introduction to Substance Use Disorders
cognitive domain 2.1 Drug Administration and the Nursing Process
Colace 30.3 Laxatives and Stool Softeners
Colazal 13.2 Antipsychotics
Colchicine 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Colcrys 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Colesevelam 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Colestid 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Colestipol 21.3 Bile Acid Sequestrants, Fibrates, and Niacin, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
collaborative practice 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
Colloid solutions 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
colloidal oncotic pressure 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Colony Stimulating Factors 8.2 Chemotherapeutic Drugs
Combigan 38.4 Antiglaucoma Drugs
Combined oral contraceptives (COCs) 36.2 Hormonal, Contraception, and Infertility Drugs
Comirnaty 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Comorbidity Tests 28.1 Introduction to Diabetes
Compazine 30.1 Antiemetics
complementary and alternative medicine (CAM) 1.2 Drug Sources, Forms, and Names
Complementary and alternative therapies 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
complete blood count (CBC) Introduction
complex focal seizures 12.1 Epilepsy and Anticonvulsant Drugs
Compro 30.1 Antiemetics
Computed tomography (CT) scan 12.1 Epilepsy and Anticonvulsant Drugs
computerized prescriber order entry (CPOE) 3.3 Documentation and Informatics
COMT inhibitors 11.2 Anti-Parkinsonian Drugs
Comtan 11.2 Anti-Parkinsonian Drugs
Concerta 13.5 CNS Stimulants and Nonstimulants
Conduction 14.1 Introduction to Pain
Cones 38.1 Introduction to the Eyes
confidentiality 3.1 Legal Considerations
Conjugate vaccines 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Conjugated estrogens 37.2 Feminizing Hormonal Therapy
Conjugated linoleic acid (CLA) 32.4 Other Drugs, Supplements, and Herbal Remedies
Conjunctival hyperemia 38.4 Antiglaucoma Drugs
conjunctivitis 38.1 Introduction to the Eyes, 38.1 Introduction to the Eyes
constipation 14.3 Opioid Agonists and Antagonists
Contact dermatitis 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
continuous glucose monitor (CGM) 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Contraceptives 36.2 Hormonal, Contraception, and Infertility Drugs
Contractility 16.2 Pumping Action of the Heart, 19.1 Heart Failure
Contrave 32.4 Other Drugs, Supplements, and Herbal Remedies
controlled substances 14.3 Opioid Agonists and Antagonists
Controlled Substances Act 1.3 Drug Classifications and Prototypes
convulsions 12.1 Epilepsy and Anticonvulsant Drugs
Copaxone 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Coreg 19.3 Beta-Adrenergic Blockers
Coreq 18.4 Beta-Adrenergic Blockers
Corgard 18.4 Beta-Adrenergic Blockers
Corlanor 19.6 Adjunct Medications Used in Heart Failure
coronary artery disease 21.1 Introduction to Lipoprotein and Apolipoproteins
Corphedra 25.1 Adrenergics and Anticholinergics
Correctol 30.3 Laxatives and Stool Softeners
Cortef 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
cortical nephrons 33.1 Introduction to the Renal System
corticosteroids 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 8.2 Chemotherapeutic Drugs, 25.2 Corticosteroids
cortisol 26.4 Glucocorticoids and Mineralocorticoids
Cortison 26.4 Glucocorticoids and Mineralocorticoids
Cortisone acetate 26.4 Glucocorticoids and Mineralocorticoids
Cortisporin 26.4 Glucocorticoids and Mineralocorticoids, 39.2 Otic Anti-inflammatories and Anti-infectives
Cortisyl 26.4 Glucocorticoids and Mineralocorticoids
Cortizone 26.4 Glucocorticoids and Mineralocorticoids
Corvert 17.4 Class III: Potassium Channel Blockers
Cosmegen 8.2 Chemotherapeutic Drugs
Coumadin 20.2 Anticoagulants
Counterfeit drugs 1.2 Drug Sources, Forms, and Names
COVID-19 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
COVID-19 vaccine, mRNA 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
COX-2 inhibitors 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Cozaar 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Creon 30.2 Antidiarrheals
Crestor 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
cromolyn sodium 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Cryoprecipitated anti-hemophilic factor (cryo) 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Crystalloid solutions 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
cultural considerations 1.4 Special Considerations
Cushing’s syndrome 26.4 Glucocorticoids and Mineralocorticoids
customary system 2.4 Dosage Calculations
cutaneous 2.3 Drug Administration Routes, Preparation, and Administration
Cutaneous Administration 2.3 Drug Administration Routes, Preparation, and Administration
Cutaneous warts 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Cutar 40.3 Psoriatic Drugs
cutting off 2.4 Dosage Calculations
Cyclessa 36.2 Hormonal, Contraception, and Infertility Drugs
cyclooxygenase 14.1 Introduction to Pain
Cyclophosphamide 8.2 Chemotherapeutic Drugs
cyclosporine 38.2 Ocular Anti-inflammatories and Anti-infectives
Cymbalta 13.1 Antidepressants
cystic fibrosis 24.3 Expectorants and Mucolytics
Cytarabine 8.2 Chemotherapeutic Drugs
cytochrome P-450 (CYP) deficiencies 32.1 Introduction to Weight Management
Cytochrome P-450 Inhibitors 7.3 Introduction to HIV, AIDS, and Antiretrovirals
cytochrome P450 2D6 14.3 Opioid Agonists and Antagonists
cytochrome P450 enzyme system 13.1 Antidepressants
Cytokines 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 14.1 Introduction to Pain
Cytomel 27.2 Thyroid and Antithyroid Drugs
cytoplasm 4.1 What Is Homeostasis?
Cytoxan 8.2 Chemotherapeutic Drugs
D
D2 (Ergocalciferol) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
D3 (Cholecalciferol) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Dabigatran 20.2 Anticoagulants
dacryoadenitis 38.1 Introduction to the Eyes
dacryocystitis 38.1 Introduction to the Eyes
Dactinomycin 8.2 Chemotherapeutic Drugs
Dalteparin 20.2 Anticoagulants
Dantrium 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Dantrolene sodium 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Dapagliflozin 19.4 Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is), 28.3 Oral Antidiabetic Drugs
Daptacel 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Daridorexant 13.4 Anxiolytics and Sedative-Hypnotics
Daunorubicin 8.2 Chemotherapeutic Drugs
Daytrana 13.5 CNS Stimulants and Nonstimulants
Dayvigo 13.4 Anxiolytics and Sedative-Hypnotics
DDAVP 26.3 Antidiuretic Hormones
Debrox 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Decadron 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 8.2 Chemotherapeutic Drugs, 26.4 Glucocorticoids and Mineralocorticoids
Declomycin 26.3 Antidiuretic Hormones
decongestant 24.1 Antihistamines and Decongestants, 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
deep vein thrombosis (DVT) 20.1 Introduction to Clotting and Coagulation
deferasirox 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
deferiprone 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Deferoxamine 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
defibrillation 22.1 Introduction to Cardiac Emergencies and Shock
Delatestryl 37.3 Masculinizing Hormonal Therapy
Delayed puberty 36.6 Androgens, Antiandrogens, and Anabolic Steroids
delirium tremens 15.3 Alcohol Use Disorder Drugs
Deltasone 25.2 Corticosteroids, 26.4 Glucocorticoids and Mineralocorticoids
deltoid 2.3 Drug Administration Routes, Preparation, and Administration
delusions 10.3 Introduction to Alzheimer’s Disease
Demadex 19.5 Diuretics, 34.2 Loop Diuretics
Demeclocycline 26.3 Antidiuretic Hormones
Demerol 14.3 Opioid Agonists and Antagonists
demyelination 11.3 Introduction to Multiple Sclerosis
Depakote 13.3 Mood Stabilizers
Depakote ER 13.3 Mood Stabilizers
dependence 2.2 Pharmacokinetics and Pharmacodynamics, 12.1 Epilepsy and Anticonvulsant Drugs
Depo-Provera 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs
Depo-testosterone 36.6 Androgens, Antiandrogens, and Anabolic Steroids, 37.3 Masculinizing Hormonal Therapy
depolarization 16.3 Conduction of Electrical Impulses
depot injections 13.2 Antipsychotics
Depression 13.1 Antidepressants
dermis 40.1 Introduction to the Skin and Its Function
Dermovate 40.3 Psoriatic Drugs
Desiccated thyroid extract 27.2 Thyroid and Antithyroid Drugs
Desloratadine 24.1 Antihistamines and Decongestants
Desmopressin 26.3 Antidiuretic Hormones
Desogestrel/ethinyl estradiol 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs
Desoxyn 13.5 CNS Stimulants and Nonstimulants
Detrol 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Detrol LA 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Dexamethasone 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 8.2 Chemotherapeutic Drugs, 26.4 Glucocorticoids and Mineralocorticoids
Dexamethasone sodium phosphate 38.2 Ocular Anti-inflammatories and Anti-infectives
Dexasone 26.4 Glucocorticoids and Mineralocorticoids
Dexmethylphenidate 13.5 CNS Stimulants and Nonstimulants
Dextenza 38.2 Ocular Anti-inflammatories and Anti-infectives
Dextroamphetamine 13.5 CNS Stimulants and Nonstimulants
Dextromethorphan 24.2 Antitussives
Diabetes Introduction
diabetes insipidus 26.3 Antidiuretic Hormones
diagnosis 2.1 Drug Administration and the Nursing Process
Diagnostic testing 27.1 Introduction to the Thyroid and Parathyroid
Diastat 12.1 Epilepsy and Anticonvulsant Drugs
diastole 16.2 Pumping Action of the Heart
diastolic blood pressure 18.1 Hypertension and Angina
Diazepam 12.1 Epilepsy and Anticonvulsant Drugs , 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics
Diazoxide 28.3 Oral Antidiabetic Drugs
Diclofenac 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Diclofenac sodium 38.2 Ocular Anti-inflammatories and Anti-infectives
diet 21.1 Introduction to Lipoprotein and Apolipoproteins
Dietary Supplement and Health Education Act (DSHEA) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Differin 40.2 Acne Drugs
Diffusion 23.3 Oxygenation and Gas Exchange
Diflucan 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
digestion 29.1 Introduction to the Gastrointestinal System and Oral Cavity
Digoxin 17.1 Introduction to Dysrhythmias, 17.6 Unclassified Antidysrhythmics, 19.6 Adjunct Medications Used in Heart Failure
dihydroxy-vitamin D3 27.1 Introduction to the Thyroid and Parathyroid
Dilantin 12.1 Epilepsy and Anticonvulsant Drugs
Dilaudid 14.3 Opioid Agonists and Antagonists
Dilt XR 17.5 Class IV: Calcium Channel Blockers
diltiazem 13.4 Anxiolytics and Sedative-Hypnotics, 17.1 Introduction to Dysrhythmias, 17.5 Class IV: Calcium Channel Blockers, 18.5 Calcium Channel Blockers, 22.2 Cardiac Emergency Drugs
Dimensional analysis 2.4 Dosage Calculations
Dimetapp 24.1 Antihistamines and Decongestants
Diovan 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Diphenhydramine 8.2 Chemotherapeutic Drugs, 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Diphenoxylate with atropine 30.2 Antidiarrheals
Diphtheria, tetanus toxoid, and acellular pertussis vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
diplopia 10.1 Introduction to Myasthenia Gravis, 11.3 Introduction to Multiple Sclerosis
direct observed therapy 15.2 Opioid Use Disorder Drugs
Direct-acting cholinergic agonists 10.2 Cholinergic Drugs
Direct-acting oral anticoagulants (DOACs) 20.2 Anticoagulants
Disease-modifying antirheumatic drugs (DMARDs) 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Disopyramide 17.1 Introduction to Dysrhythmias
distribution 2.2 Pharmacokinetics and Pharmacodynamics
Distributive shock 22.1 Introduction to Cardiac Emergencies and Shock
Disulfiram 15.3 Alcohol Use Disorder Drugs
Ditropan 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Ditropan XL 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Diuretic braking 34.1 Introduction to Diuretics
diuretic drugs 5.1 Fluid Volume
Diuretic resistance 34.1 Introduction to Diuretics
Diuretic therapy Introduction
Diuretics 18.6 Diuretics, 19.5 Diuretics
Diuril 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
Divigel 36.2 Hormonal, Contraception, and Infertility Drugs
DOAC Reversal Agents 20.2 Anticoagulants
Dobutamine 22.2 Cardiac Emergency Drugs
Docetaxel 8.2 Chemotherapeutic Drugs
documentation 3.3 Documentation and Informatics
Docusate calcium 30.3 Laxatives and Stool Softeners
Docusate sodium 30.3 Laxatives and Stool Softeners
Dofetilide 17.1 Introduction to Dysrhythmias, 17.4 Class III: Potassium Channel Blockers
Dolophine 14.3 Opioid Agonists and Antagonists, 15.2 Opioid Use Disorder Drugs
Dolutegravir/rilpivirine 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Donepezil 10.4 Alzheimer’s Drugs
Donepezil transdermal 10.4 Alzheimer’s Drugs
Dopamine 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 22.2 Cardiac Emergency Drugs
Dopamine agonist 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs , 13.2 Antipsychotics
Dopamine antagonists 11.2 Anti-Parkinsonian Drugs
Dopaminergic 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs
Dornase alfa 24.3 Expectorants and Mucolytics
Dorzolamide 2% solution 38.4 Antiglaucoma Drugs
Dosage calculations 2.4 Dosage Calculations
downregulated 15.3 Alcohol Use Disorder Drugs
Doxazosin 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Doxil 8.2 Chemotherapeutic Drugs
Doxorubicin 8.2 Chemotherapeutic Drugs
Doxycin 40.2 Acne Drugs
Doxycycline 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Doxycycline hyclate 40.2 Acne Drugs
Drisdol 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Dronabinol 30.1 Antiemetics
Dronedarone 17.1 Introduction to Dysrhythmias, 17.4 Class III: Potassium Channel Blockers
Drospirenone/ethinyl estradiol 36.2 Hormonal, Contraception, and Infertility Drugs
drug 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
drug administration Introduction
drug calculation 2.4 Dosage Calculations
Drug Enforcement Administration (DEA) 1.2 Drug Sources, Forms, and Names, 15.2 Opioid Use Disorder Drugs
drug formulary 1.4 Special Considerations
drug label 2.4 Dosage Calculations
drug prototype 1.3 Drug Classifications and Prototypes
Drug Supply Chain Security Act 1.2 Drug Sources, Forms, and Names
Drug tolerance 12.1 Epilepsy and Anticonvulsant Drugs
Dry macular degeneration (DMD) 38.1 Introduction to the Eyes
Dulaglutide 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Dulcolax 30.3 Laxatives and Stool Softeners
Duloxetine 13.1 Antidepressants
Duragesic 14.3 Opioid Agonists and Antagonists
Duramorph 14.3 Opioid Agonists and Antagonists
duration of action 2.2 Pharmacokinetics and Pharmacodynamics
Durvalumab 8.4 Biologic Response Modifiers
Dutasteride 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Duvoid 35.4 Urinary Stimulants
Dyrenium 18.6 Diuretics, 34.4 Potassium-Sparing Diuretics
dysarthria 10.1 Introduction to Myasthenia Gravis, 11.3 Introduction to Multiple Sclerosis
dyskinesias 11.2 Anti-Parkinsonian Drugs
Dyslipidemia 21.1 Introduction to Lipoprotein and Apolipoproteins
dysmenorrhea 31.3 Pepsin Inhibitors and Prostaglandin Analogues
dysphagia 10.1 Introduction to Myasthenia Gravis, 11.3 Introduction to Multiple Sclerosis
Dysrhythmia 16.3 Conduction of Electrical Impulses, 17.1 Introduction to Dysrhythmias, 17.1 Introduction to Dysrhythmias, 22.1 Introduction to Cardiac Emergencies and Shock
dystonia 11.1 Introduction to Parkinson’s Disease, 13.2 Antipsychotics
E
E (Alpha-tocopherol) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
ear Introduction
eardrum 39.1 Introduction to the Ears
East Asian 32.1 Introduction to Weight Management
eating disorder 32.2 Anorexiants
Echinacea 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Echinocandins 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 39.1 Introduction to the Ears
echothiopate 10.2 Cholinergic Drugs
eczema 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Edoxaban 20.2 Anticoagulants
EDTA 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
effector 4.1 What Is Homeostasis?
Effexor 13.1 Antidepressants
Effient 20.3 Antiplatelets
ejection fraction 19.1 Heart Failure
Eldepryl 11.2 Anti-Parkinsonian Drugs
Electrocardiography (EKG or ECG) 16.3 Conduction of Electrical Impulses
Electroencephalogram (EEG) 12.1 Epilepsy and Anticonvulsant Drugs
electrolyte balance 4.1 What Is Homeostasis?
Electrolytes 5.2 Electrolytes
electronic health record 3.1 Legal Considerations, 3.3 Documentation and Informatics
electronic medication administration record 3.3 Documentation and Informatics
Eletriptan 12.2 Migraine Headaches and Migraine Headache Drugs
Elidel 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Elimite 7.6 Antiparasitic and Anthelminthic Drugs
Eliphos 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Eliquis 20.2 Anticoagulants
Ella 36.2 Hormonal, Contraception, and Infertility Drugs
Ellence 8.2 Chemotherapeutic Drugs
Eloxatin 8.2 Chemotherapeutic Drugs
embolization 8.1 Introduction to Cancer and Phases of Cancer Therapy
Emend 30.1 Antiemetics
Emerphed 25.1 Adrenergics and Anticholinergics
emochromatosis 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Empagliflozin 19.4 Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is), 28.3 Oral Antidiabetic Drugs
Emphysema 23.2 Introduction to the Lower Respiratory System
Emsam 13.1 Antidepressants
Emulsoil 30.3 Laxatives and Stool Softeners
Emverm 7.6 Antiparasitic and Anthelminthic Drugs
Enalapril 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Enbrel 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 40.3 Psoriatic Drugs
end-stage renal disease (ESRD) 34.1 Introduction to Diuretics
Endocrine glands Introduction
endocrine system Introduction
Enfuvirtide 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Enoxaparin 20.2 Anticoagulants, 20.2 Anticoagulants
entacapone 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs
enteral 2.3 Drug Administration Routes, Preparation, and Administration
Enteral administration 1.2 Drug Sources, Forms, and Names, 2.3 Drug Administration Routes, Preparation, and Administration
Entresto 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Ephedrine 25.1 Adrenergics and Anticholinergics
epidermis 40.1 Introduction to the Skin and Its Function
epiglottis 29.2 Introduction to the Esophagus and Stomach
Epilepsy 12.1 Epilepsy and Anticonvulsant Drugs
epinephrine 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 22.2 Cardiac Emergency Drugs, 22.3 Shock Drugs, 25.1 Adrenergics and Anticholinergics, 25.1 Adrenergics and Anticholinergics
Epipen 25.1 Adrenergics and Anticholinergics
Epirubicin 8.2 Chemotherapeutic Drugs
Episcleritis 38.1 Introduction to the Eyes
Eplerenone 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 34.4 Potassium-Sparing Diuretics
Epoetin alfa 8.2 Chemotherapeutic Drugs
Epogen 8.2 Chemotherapeutic Drugs
Eptifibatide 20.3 Antiplatelets
equator 11.3 Introduction to Multiple Sclerosis
Eraxis 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 39.1 Introduction to the Ears
Ergocalciferol 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Ergot alkaloids 12.2 Migraine Headaches and Migraine Headache Drugs
ergot derivatives 11.2 Anti-Parkinsonian Drugs
Erlotinib 8.4 Biologic Response Modifiers
erythema multiforme 35.1 Urinary Anti-infectives
erythrocytes 8.2 Chemotherapeutic Drugs, Introduction
Erythrocytopenia 8.2 Chemotherapeutic Drugs
Erythromycin 0.5% 38.2 Ocular Anti-inflammatories and Anti-infectives
Erythropoietin production 33.1 Introduction to the Renal System
Escitalopram 13.1 Antidepressants
Esmolol 17.1 Introduction to Dysrhythmias, 17.3 Class II: Beta Adrenergic Blockers
Esomeprazole 31.2 Histamine Blockers and Proton-Pump Inhibitors
Essential fatty acids (EFAs) 32.1 Introduction to Weight Management
Estrace 36.2 Hormonal, Contraception, and Infertility Drugs
Estraderm Transdermal 36.2 Hormonal, Contraception, and Infertility Drugs
estradiol 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs
Estradiol cypionate 37.2 Feminizing Hormonal Therapy
Estradiol levonorgestrel 36.2 Hormonal, Contraception, and Infertility Drugs
Estradiol patch 37.2 Feminizing Hormonal Therapy
Estradiol valerate 37.2 Feminizing Hormonal Therapy
estrogen 36.1 Review of the Female Reproductive System , 36.2 Hormonal, Contraception, and Infertility Drugs
Estrogen Derivatives 36.2 Hormonal, Contraception, and Infertility Drugs
Estrogen receptor modulators (ERMs) 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
estrogen therapy 36.2 Hormonal, Contraception, and Infertility Drugs
Estropipate 36.2 Hormonal, Contraception, and Infertility Drugs
Eszopiclone 13.4 Anxiolytics and Sedative-Hypnotics
Etanercept 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 40.3 Psoriatic Drugs
Ethambutol 7.5 Introduction to Tuberculosis and Antitubercular Drugs
ethanol 15.3 Alcohol Use Disorder Drugs
Ethical care 3.2 Drug Errors and Prevention
Ethics 3.2 Drug Errors and Prevention
Ethinyl estradiol desogestrel 36.2 Hormonal, Contraception, and Infertility Drugs
Ethosuximide (Zarontin) 12.1 Epilepsy and Anticonvulsant Drugs
Etoposide 8.2 Chemotherapeutic Drugs
Etravirine 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Etrivex 40.3 Psoriatic Drugs
Eulexin 8.3 Hormonal Therapy
Eustachian tube 39.1 Introduction to the Ears
Evaluation 2.1 Drug Administration and the Nursing Process
Evolocumab 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
exacerbations 11.3 Introduction to Multiple Sclerosis
excretion 2.2 Pharmacokinetics and Pharmacodynamics
Exelon 10.4 Alzheimer’s Drugs
Exemestane 8.3 Hormonal Therapy
Exenatide 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
exfoliative dermatitis 35.1 Urinary Anti-infectives
Exorex 40.3 Psoriatic Drugs
Expectorants 24.3 Expectorants and Mucolytics
external auditory canal 39.1 Introduction to the Ears
External ocular structures 38.1 Introduction to the Eyes
extracellular fluid 4.1 What Is Homeostasis?, 5.1 Fluid Volume
extrapyramidal symptoms 13.2 Antipsychotics, 30.1 Antiemetics
extravasate 8.2 Chemotherapeutic Drugs
eye Introduction
Ezetimibe 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.4 Cholesterol Absorption Inhibitors, 21.4 Cholesterol Absorption Inhibitors
F
Factor V Leiden 20.1 Introduction to Clotting and Coagulation
Factor VIII 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Familial hypercholesterolemia 21.1 Introduction to Lipoprotein and Apolipoproteins
Famotidine 31.2 Histamine Blockers and Proton-Pump Inhibitors
Farxiga 19.4 Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is), 28.3 Oral Antidiabetic Drugs
Faslodex 8.3 Hormonal Therapy
fasting blood glucose 28.1 Introduction to Diabetes
Fat emulsions 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Fat-soluble vitamins 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Febrile neutropenia 8.2 Chemotherapeutic Drugs
Febrile reactions 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
feedback loop 4.1 What Is Homeostasis?
Feldene 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
female reproductive system 36.1 Review of the Female Reproductive System
female-to-male (FTM) transition 37.3 Masculinizing Hormonal Therapy
fenestrated capillaries 33.1 Introduction to the Renal System
Fenofibrate 21.3 Bile Acid Sequestrants, Fibrates, and Niacin, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Fenofibric acid 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Fentanyl 14.3 Opioid Agonists and Antagonists
Fetzima 13.1 Antidepressants
Fexofenadine 24.1 Antihistamines and Decongestants
Fiberall 30.3 Laxatives and Stool Softeners
FiberCon 30.3 Laxatives and Stool Softeners
Fibrates 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
fibrinogen 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products, 20.1 Introduction to Clotting and Coagulation
fibrinolysis 20.1 Introduction to Clotting and Coagulation
fibrosis 8.2 Chemotherapeutic Drugs
Filgrastim 8.2 Chemotherapeutic Drugs
Finacea 40.2 Acne Drugs
Finasteride 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Finevin 40.2 Acne Drugs
Finzala 36.2 Hormonal, Contraception, and Infertility Drugs
first-day start method 36.2 Hormonal, Contraception, and Infertility Drugs
first-generation antihistamines 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
First-generation antipsychotics 13.2 Antipsychotics, 15.3 Alcohol Use Disorder Drugs
First-generation short-acting sulfonylureas 28.3 Oral Antidiabetic Drugs
first-pass effect 2.2 Pharmacokinetics and Pharmacodynamics
Flagyl 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them, 7.6 Antiparasitic and Anthelminthic Drugs, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Flavoxate hydrochloride 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics, 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Flecainide 17.1 Introduction to Dysrhythmias, 17.2 Class I: Sodium Channel Blockers
Flomax 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Flovent HFA 25.2 Corticosteroids
Floxin 39.2 Otic Anti-inflammatories and Anti-infectives
Fluconazole 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Flucytosine 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Fludara 8.2 Chemotherapeutic Drugs
Fludarabine 8.2 Chemotherapeutic Drugs
fluid balance 4.1 What Is Homeostasis?
fluid imbalance 5.1 Fluid Volume
Fluid volume 5.1 Fluid Volume
Fluid volume deficit 5.1 Fluid Volume
Fluid volume excess 5.1 Fluid Volume
fluid volume overload 34.5 Thiazide and Thiazide-Like Diuretics
Fluid volume replacement 5.1 Fluid Volume
fluoroquinolones 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Fluoxetine 13.1 Antidepressants, 13.1 Antidepressants
Fluoxymesterone 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Fluphenazine 13.2 Antipsychotics
Flutamide 8.3 Hormonal Therapy
Fluticasone 25.2 Corticosteroids
Fluvastatin 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Fluvastatin XL 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Fluzone 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
focal seizures 12.1 Epilepsy and Anticonvulsant Drugs
Focalin 13.5 CNS Stimulants and Nonstimulants
Folate Antimetabolites 8.2 Chemotherapeutic Drugs
Follicle-stimulating hormone (FSH) 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus, 36.1 Review of the Female Reproductive System
Follistim AQ 36.2 Hormonal, Contraception, and Infertility Drugs
Follitropin 36.2 Hormonal, Contraception, and Infertility Drugs
Food and Drug Administration (FDA) 1.2 Drug Sources, Forms, and Names
food desert 32.1 Introduction to Weight Management
foramen of Monro 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
forms of medication 2.3 Drug Administration Routes, Preparation, and Administration
Fosamax 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Fosfomycin tromethamine 35.1 Urinary Anti-infectives, 35.1 Urinary Anti-infectives
Fosinopril 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Fragmin 20.2 Anticoagulants
full mu opioid receptor agonist 15.2 Opioid Use Disorder Drugs
fulminant hepatic necrosis 12.3 Intracranial Emergencies and Intracranial Emergency Drugs, 35.1 Urinary Anti-infectives
Fulvestrant 8.3 Hormonal Therapy
Fungal infections 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Fungi 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Furadantin 35.1 Urinary Anti-infectives
Furoscix 34.2 Loop Diuretics, 34.2 Loop Diuretics
Furosemide 19.5 Diuretics, 34.2 Loop Diuretics, 34.2 Loop Diuretics
Fusion Pump Inhibitors 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Fuzeon 7.3 Introduction to HIV, AIDS, and Antiretrovirals
G
GABA structural analogs 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Gabapentin 11.4 Drugs Used in the Treatment of Multiple Sclerosis, 12.1 Epilepsy and Anticonvulsant Drugs
Galantamine 10.4 Alzheimer’s Drugs
Gamma-aminobutyric acid (GABA) 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 12.1 Epilepsy and Anticonvulsant Drugs
Gamma-Aminobutyric Acid Structural Analogs 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Garamycin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 38.2 Ocular Anti-inflammatories and Anti-infectives
Gardasil 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Garlic 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Gas exchange 23.3 Oxygenation and Gas Exchange
gastritis 29.2 Introduction to the Esophagus and Stomach
gastroesophageal reflux disease (GERD) 29.2 Introduction to the Esophagus and Stomach, Introduction
gastrointestinal (GI) system Introduction
Gemcitabine 8.2 Chemotherapeutic Drugs, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Gemfibrozil 21.3 Bile Acid Sequestrants, Fibrates, and Niacin, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Gemzar 8.2 Chemotherapeutic Drugs
gender and racial bias 18.1 Hypertension and Angina
Gender dysphoria 37.1 Overview of Transgender and Nonbinary Health
Gender expression 37.1 Overview of Transgender and Nonbinary Health
Gender fluid 37.1 Overview of Transgender and Nonbinary Health
Gender identity 37.1 Overview of Transgender and Nonbinary Health
gender nonconforming 37.1 Overview of Transgender and Nonbinary Health
gender-related topics 37.1 Overview of Transgender and Nonbinary Health
generalized seizures 12.1 Epilepsy and Anticonvulsant Drugs
Generic names 1.2 Drug Sources, Forms, and Names
Gentamicin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Gentamicin sulfate 0.3% 38.2 Ocular Anti-inflammatories and Anti-infectives
Geodon 13.2 Antipsychotics
geographic regions 11.1 Introduction to Parkinson’s Disease
geriatric 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
gestational diabetes 28.1 Introduction to Diabetes
Ghrelin 32.1 Introduction to Weight Management
Ginger 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
gingival hyperplasia 12.1 Epilepsy and Anticonvulsant Drugs
Ginseng 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Glatiramer acetate 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Glaucoma 38.1 Introduction to the Eyes
Glimepiride 28.3 Oral Antidiabetic Drugs
Glipizide 28.3 Oral Antidiabetic Drugs, 28.3 Oral Antidiabetic Drugs
glitazones 28.3 Oral Antidiabetic Drugs
Glomerular capillary hydrostatic pressure 33.1 Introduction to the Renal System
Glomerular capillary oncotic pressure 33.1 Introduction to the Renal System
Glomerular filtration 33.1 Introduction to the Renal System
glomerular filtration rate 33.1 Introduction to the Renal System, 33.2 Renal-Associated Fluid Volume Excess, 34.1 Introduction to Diuretics
Glomerulopathies 33.1 Introduction to the Renal System
glomerulus 33.1 Introduction to the Renal System
GLP-1 receptor agonists 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Glucagon 28.1 Introduction to Diabetes, 28.3 Oral Antidiabetic Drugs, 32.1 Introduction to Weight Management
Glucagon-Like Peptide-1 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs, 32.4 Other Drugs, Supplements, and Herbal Remedies
Glucocorticoids 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus, 26.4 Glucocorticoids and Mineralocorticoids
Glucomannan 32.4 Other Drugs, Supplements, and Herbal Remedies
Gluconeogenesis 33.1 Introduction to the Renal System
Glucophage 28.3 Oral Antidiabetic Drugs
Glucophage XR 28.3 Oral Antidiabetic Drugs
glucose 5.2 Electrolytes
glucose tablets 28.1 Introduction to Diabetes
Glucotrol 28.3 Oral Antidiabetic Drugs
Glucotrol XL 28.3 Oral Antidiabetic Drugs
Glucovance 28.3 Oral Antidiabetic Drugs
Glutamate 9.3 Characteristics of Drugs to Treat Nervous System Disorders
Glyburide 28.3 Oral Antidiabetic Drugs
Glyburide/metformin 28.3 Oral Antidiabetic Drugs
glycemic index (GI) 32.1 Introduction to Weight Management
glycolysis 5.2 Electrolytes
Glycopeptides 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
glycosylated hemoglobin (A1c) 28.1 Introduction to Diabetes
Glyset 28.3 Oral Antidiabetic Drugs
Gocovri 11.2 Anti-Parkinsonian Drugs
goiter 27.2 Thyroid and Antithyroid Drugs
gonadotropin-releasing hormone (GnRH) 36.1 Review of the Female Reproductive System
Gonal-F 36.2 Hormonal, Contraception, and Infertility Drugs
Gonal-F RFF 36.2 Hormonal, Contraception, and Infertility Drugs
Gonorrhea 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Good Manufacturing Practices (GMPs) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
grades of hypertension 18.1 Hypertension and Angina
grand mal seizures 12.1 Epilepsy and Anticonvulsant Drugs
Granisetron 30.1 Antiemetics
granulocytes 8.2 Chemotherapeutic Drugs
granulocytopenia 8.2 Chemotherapeutic Drugs
Graves’ disease 27.1 Introduction to the Thyroid and Parathyroid
Green Tea Extract 32.4 Other Drugs, Supplements, and Herbal Remedies
Growth hormone (GH) 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
growth hormone receptor antagonists 26.2 Growth Hormones and Suppressants
growth hormone suppressants 26.2 Growth Hormones and Suppressants
Guaifenesin 24.3 Expectorants and Mucolytics
Guanfacine 13.5 CNS Stimulants and Nonstimulants
Guarana 32.4 Other Drugs, Supplements, and Herbal Remedies
gynecomastia 31.2 Histamine Blockers and Proton-Pump Inhibitors, 37.2 Feminizing Hormonal Therapy
H
H. influenza 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
H1 receptors 24.1 Antihistamines and Decongestants
Halcion 13.4 Anxiolytics and Sedative-Hypnotics
Haldol 13.2 Antipsychotics, 15.3 Alcohol Use Disorder Drugs
half-life 2.2 Pharmacokinetics and Pharmacodynamics
hallucinations 10.3 Introduction to Alzheimer’s Disease
Haloperidol 13.2 Antipsychotics, 15.3 Alcohol Use Disorder Drugs
Halotestin 36.6 Androgens, Antiandrogens, and Anabolic Steroids
hard-stop alert 3.3 Documentation and Informatics
Hashimoto thyroiditis 27.1 Introduction to the Thyroid and Parathyroid
Havrix 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Hawthorn 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
HCTZ 19.5 Diuretics
HDL-cholesterol 21.1 Introduction to Lipoprotein and Apolipoproteins
Headaches 12.2 Migraine Headaches and Migraine Headache Drugs
Health equity 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Health Information Technology for Economic and Clinical Health (HITECH) Act 3.1 Legal Considerations
Health Insurance Portability and Accountability Act 3.1 Legal Considerations
Health literacy 2.1 Drug Administration and the Nursing Process
Healthy People 2030 Introduction
Heart failure 19.1 Heart Failure
heart failure with preserved ejection fraction (HFpEF) 19.1 Heart Failure
heart failure with reduced ejection fraction (HFrEF) 19.1 Heart Failure
heart rate 18.1 Hypertension and Angina, 19.1 Heart Failure
Helminths 7.6 Antiparasitic and Anthelminthic Drugs
Hemabate 36.3 Uterine Motility Drugs and Lactation Considerations
hematocrit Introduction, 33.2 Renal-Associated Fluid Volume Excess
Hematologic cancers 8.1 Introduction to Cancer and Phases of Cancer Therapy
heme synthesis 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
hemoglobin Introduction
Hemolytic reactions 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
hemorrhagic cystitis 8.2 Chemotherapeutic Drugs
hemostasis 20.1 Introduction to Clotting and Coagulation
Heparin 20.2 Anticoagulants, 20.2 Anticoagulants
Heparin-induced thrombocytopenia (HIT) 20.2 Anticoagulants
Hepatitis 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Hepatitis A vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Hepatitis B vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
hepatotoxicity 14.2 Nonopioid Analgesics
Herbs 32.1 Introduction to Weight Management
herd immunity 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
herpes 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Herpes simplex virus (HSV) 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
High-density lipoproteins (HDL or HDL-cholesterol) 21.1 Introduction to Lipoprotein and Apolipoproteins
hilum 33.1 Introduction to the Renal System
Hiprex 35.1 Urinary Anti-infectives
Hispanic 11.3 Introduction to Multiple Sclerosis, 28.1 Introduction to Diabetes, 28.1 Introduction to Diabetes, 32.1 Introduction to Weight Management, 38.1 Introduction to the Eyes
Histamine 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 23.1 Introduction to the Upper Respiratory System, 24.1 Antihistamines and Decongestants, 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Histamine Blockers 31.2 Histamine Blockers and Proton-Pump Inhibitors
Histamine type-2 receptor antagonists 29.3 Introduction to the Small and Large Intestines
histamine-1 receptor antagonist 13.2 Antipsychotics
HIV transmission 7.3 Introduction to HIV, AIDS, and Antiretrovirals
HMG CoA reductase 21.1 Introduction to Lipoprotein and Apolipoproteins
Homeostasis 4.1 What Is Homeostasis?, 4.3 Maintaining Homeostasis, 4.4 Negative Feedback Loop, 9.1 Introduction to the Nervous System, Introduction
homeostatic mechanism 4.3 Maintaining Homeostasis
homeostatic response system 4.4 Negative Feedback Loop
Hoodia gordonii 32.4 Other Drugs, Supplements, and Herbal Remedies
hordeolum 38.1 Introduction to the Eyes
hormonal therapy 8.3 Hormonal Therapy
hormone replacement therapy 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs
household system 2.4 Dosage Calculations
Humalog 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Human chorionic gonadotropin (hCG) 36.2 Hormonal, Contraception, and Infertility Drugs
human immunodeficiency virus 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Human papillomavirus 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Human regular insulin 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Humira 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 40.3 Psoriatic Drugs
Humulin N 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Humulin R 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Hydantoins 12.1 Epilepsy and Anticonvulsant Drugs
Hydralazine and isosorbide dinitrate 19.6 Adjunct Medications Used in Heart Failure
hydrochloric (HCl) acid 29.1 Introduction to the Gastrointestinal System and Oral Cavity, 29.2 Introduction to the Esophagus and Stomach, Introduction
hydrochloride 14.3 Opioid Agonists and Antagonists
Hydrochlorothiazide 18.6 Diuretics, 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
Hydrocortisone 26.4 Glucocorticoids and Mineralocorticoids, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Hydrodiuril 34.5 Thiazide and Thiazide-Like Diuretics
Hydromorphone 14.3 Opioid Agonists and Antagonists
hydrostatic pressure 4.3 Maintaining Homeostasis
Hydroxychloroquine 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
hydroxyethyl starch (HES) products 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Hydroxyzine 30.1 Antiemetics
Hyperacidity Introduction
Hypercalcemia 5.2 Electrolytes, 31.1 Antacids
Hyperchloremia 5.2 Electrolytes
hypercholesterolemia 21.1 Introduction to Lipoprotein and Apolipoproteins
hypercoagulable 20.1 Introduction to Clotting and Coagulation
Hyperglycemia 28.1 Introduction to Diabetes, 32.1 Introduction to Weight Management
Hyperkalemia 5.2 Electrolytes, 34.1 Introduction to Diuretics
Hyperlipidemia 21.1 Introduction to Lipoprotein and Apolipoproteins
Hypermagnesemia 5.2 Electrolytes, 31.1 Antacids
Hypernatremia 5.2 Electrolytes, 31.1 Antacids, 34.1 Introduction to Diuretics
Hyperopia 38.1 Introduction to the Eyes
Hyperosmolality 4.2 Osmolality
Hyperparathyroidism 27.1 Introduction to the Thyroid and Parathyroid
Hyperphosphatemia 5.2 Electrolytes
Hyperplasia 32.1 Introduction to Weight Management
hyperpyrexia 13.1 Antidepressants
hypersomnia 13.1 Antidepressants
Hypertension 16.1 Introduction to the Heart, Circulation, and Blood Flow, Introduction
Hypertonic solutions 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Hypertonicity 4.2 Osmolality
hypertriglyceridemia 21.1 Introduction to Lipoprotein and Apolipoproteins
Hypertrophy 32.1 Introduction to Weight Management
hypervolemia 5.1 Fluid Volume, 34.1 Introduction to Diuretics
hyphema 38.2 Ocular Anti-inflammatories and Anti-infectives
hypnagogic hallucinations 13.5 CNS Stimulants and Nonstimulants
Hypocalcemia 5.2 Electrolytes
Hypochloremia 5.2 Electrolytes
hypodermis 40.1 Introduction to the Skin and Its Function
Hypoglycemia 28.1 Introduction to Diabetes
Hypoglycemia drugs 28.3 Oral Antidiabetic Drugs
Hypogonadism 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Hypokalemia 5.2 Electrolytes, 34.1 Introduction to Diuretics
Hypomagnesemia 5.2 Electrolytes
Hyponatremia 5.2 Electrolytes, 34.1 Introduction to Diuretics
Hypoosmolality 4.2 Osmolality
Hypoparathyroidism 27.1 Introduction to the Thyroid and Parathyroid
Hypophosphatemia 5.2 Electrolytes, 31.1 Antacids
hypophysis 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
hypotension 18.1 Hypertension and Angina
hypothalamus 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
Hypothyroidism 27.1 Introduction to the Thyroid and Parathyroid
Hypotonic solutions 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Hypotonicity 4.2 Osmolality
hypovolemia 5.1 Fluid Volume, 34.2 Loop Diuretics
Hypovolemic shock 22.1 Introduction to Cardiac Emergencies and Shock, 22.1 Introduction to Cardiac Emergencies and Shock, 22.3 Shock Drugs
hypoxemia 23.3 Oxygenation and Gas Exchange
I
Ibandronate 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Ibrutinib 8.4 Biologic Response Modifiers
Ibuprofen 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 14.2 Nonopioid Analgesics
Ibutilide 17.1 Introduction to Dysrhythmias, 17.4 Class III: Potassium Channel Blockers
Icosapent ethyl 21.1 Introduction to Lipoprotein and Apolipoproteins
idiopathic pain 14.1 Introduction to Pain
idiopathic seizure 12.1 Epilepsy and Anticonvulsant Drugs
If current inhibitor 19.6 Adjunct Medications Used in Heart Failure
Ilotycin 38.2 Ocular Anti-inflammatories and Anti-infectives
Imbruvica 8.4 Biologic Response Modifiers
Imdur 18.7 Nitrates
Imfinzi 8.4 Biologic Response Modifiers
Iminostilbenes 12.1 Epilepsy and Anticonvulsant Drugs
Imitrex 12.2 Migraine Headaches and Migraine Headache Drugs
immune system Introduction, 7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections, 24.1 Antihistamines and Decongestants
Immunity 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
immunizations 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
immunocompromised 7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections
immunoglobulins 11.3 Introduction to Multiple Sclerosis
Immunomodulators 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Immunosuppressants 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Imodium 30.2 Antidiarrheals
Impetigo 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
implanted contraceptive devices 36.2 Hormonal, Contraception, and Infertility Drugs
implementation 2.1 Drug Administration and the Nursing Process
Improvera 36.2 Hormonal, Contraception, and Infertility Drugs
Imuran 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Inactivated poliovirus vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Inactivated vaccines 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Inbrija 11.2 Anti-Parkinsonian Drugs
Inclisiran 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
increased intracranial pressure 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
incretin mimetic 32.4 Other Drugs, Supplements, and Herbal Remedies
incus 39.1 Introduction to the Ears
Indapamide 19.5 Diuretics
Inderal 13.5 CNS Stimulants and Nonstimulants, 17.3 Class II: Beta Adrenergic Blockers
Inderal LA 18.4 Beta-Adrenergic Blockers
indication 2.1 Drug Administration and the Nursing Process
Indirect-acting cholinergic agonists 10.2 Cholinergic Drugs
Indocin 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Indomethacin 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
infarction 22.1 Introduction to Cardiac Emergencies and Shock
Infection 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
infertility drugs 36.2 Hormonal, Contraception, and Infertility Drugs
Inflammation 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
inflammatory response 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Infliximab 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 40.3 Psoriatic Drugs
Influenza 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Influenza vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
ingestion 29.1 Introduction to the Gastrointestinal System and Oral Cavity
inhaled corticosteroids 23.2 Introduction to the Lower Respiratory System
Injectable anticoagulant medications 20.2 Anticoagulants
innate immune system 6.1 Introduction to Immunity
innate immunity 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations, 7.1 Introduction to Bacterial, Viral/COVID-19, and Fungal Infections
Inotrope 22.2 Cardiac Emergency Drugs
inotropic agent 22.2 Cardiac Emergency Drugs
Inspra 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 34.4 Potassium-Sparing Diuretics
Institute for Safe Medication Practices 3.2 Drug Errors and Prevention, 3.3 Documentation and Informatics, 17.1 Introduction to Dysrhythmias, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
insulin 5.2 Electrolytes, Introduction, 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs, 32.1 Introduction to Weight Management
Insulin aspart 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Insulin degludec 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Insulin detemir 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Insulin glargine 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Insulin glulisine 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Insulin isophane NPH 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Insulin lispro 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
insulin pen 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
insulin pump 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
insulin resistance 32.1 Introduction to Weight Management
insulin sensitizers 28.3 Oral Antidiabetic Drugs
Intal 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Integrase strand transfer inhibitors 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Integrelin 20.3 Antiplatelets
Integrity 3.2 Drug Errors and Prevention
Intelence 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Interferon beta-1a 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Interferon beta-1b 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Interferons 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Intermediate-acting insulin 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Internal ocular structures 38.1 Introduction to the Eyes
International normalized ratio (INR) 20.2 Anticoagulants
interprofessional (IP) collaboration 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
interstitial compartment 4.1 What Is Homeostasis?
interstitial cystitis 35.3 Urinary Analgesics
Intoxication 15.1 Introduction to Substance Use Disorders
intracellular fluid 4.1 What Is Homeostasis?, 5.1 Fluid Volume
Intracranial emergencies 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
intracranial hypertension 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Intracranial pressure monitoring 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Intramuscular injections 1.2 Drug Sources, Forms, and Names, 2.2 Pharmacokinetics and Pharmacodynamics, 2.3 Drug Administration Routes, Preparation, and Administration
Intraocular pressure (IOP) 38.1 Introduction to the Eyes
intrauterine devices (IUDs) 36.2 Hormonal, Contraception, and Infertility Drugs
intravascular compartment 4.1 What Is Homeostasis?
intravenous 1.2 Drug Sources, Forms, and Names, 2.2 Pharmacokinetics and Pharmacodynamics
Intravenous (IV) fluid therapy 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Intravenous insulin 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Intravenous medications 2.3 Drug Administration Routes, Preparation, and Administration
intrinsic activity 2.2 Pharmacokinetics and Pharmacodynamics, 10.2 Cholinergic Drugs
Introvale 36.2 Hormonal, Contraception, and Infertility Drugs
Intuniv 13.5 CNS Stimulants and Nonstimulants, 13.5 CNS Stimulants and Nonstimulants
Invega 13.2 Antipsychotics, 13.5 CNS Stimulants and Nonstimulants
iodine 27.2 Thyroid and Antithyroid Drugs
iodotyrosines 27.2 Thyroid and Antithyroid Drugs
ions 4.1 What Is Homeostasis?
IPOL 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Ipratropium bromide 25.1 Adrenergics and Anticholinergics
Irreversible AChE Inhibitors 10.2 Cholinergic Drugs
Irritable Bowel Syndrome 29.3 Introduction to the Small and Large Intestines
ischemia 22.1 Introduction to Cardiac Emergencies and Shock
ischemic stroke 20.1 Introduction to Clotting and Coagulation
Isentress 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Iso-osmolality 4.2 Osmolality
Isoniazid 7.5 Introduction to Tuberculosis and Antitubercular Drugs
Isordil 18.7 Nitrates
Isosorbide dinitrate 18.7 Nitrates
Isosorbide mononitrate 18.7 Nitrates
Isotonic IV solutions 22.3 Shock Drugs
Isotonic solutions 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Isotonicity 4.2 Osmolality
Isovit 7.5 Introduction to Tuberculosis and Antitubercular Drugs
Ivabradine 19.6 Adjunct Medications Used in Heart Failure
J
JAMA Network 21.1 Introduction to Lipoprotein and Apolipoproteins
Janumet 11.2 Anti-Parkinsonian Drugs , 28.3 Oral Antidiabetic Drugs
Januvia 28.3 Oral Antidiabetic Drugs
Jardiance 19.4 Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is), 28.3 Oral Antidiabetic Drugs
Joint Commission 3.2 Drug Errors and Prevention, 3.3 Documentation and Informatics
JULUCA 7.3 Introduction to HIV, AIDS, and Antiretrovirals
just culture 3.2 Drug Errors and Prevention
Justice 3.2 Drug Errors and Prevention
juxtamedullary nephrons 33.1 Introduction to the Renal System
Jynarque 26.3 Antidiuretic Hormones
K
K (Phytonadione) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Kalcinate 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Kaopectate 30.2 Antidiarrheals
Kapvay 13.5 CNS Stimulants and Nonstimulants
Kefauver-Harris Amendments 1.2 Drug Sources, Forms, and Names
Keflex 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Kelp 32.1 Introduction to Weight Management
Kengreal 20.3 Antiplatelets
Keppra 12.1 Epilepsy and Anticonvulsant Drugs
Keratitis 38.1 Introduction to the Eyes
Keratoconjunctivitis sicca 38.1 Introduction to the Eyes
Ketalar 38.2 Ocular Anti-inflammatories and Anti-infectives
ketoacidosis 28.1 Introduction to Diabetes
ketogenic diet 21.1 Introduction to Lipoprotein and Apolipoproteins
ketorolac 38.2 Ocular Anti-inflammatories and Anti-infectives
Ketorolac tromethamine 38.2 Ocular Anti-inflammatories and Anti-infectives
Keytruda 8.4 Biologic Response Modifiers
kidneys 33.1 Introduction to the Renal System
Klonopin 12.1 Epilepsy and Anticonvulsant Drugs , 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics
Konysl 30.3 Laxatives and Stool Softeners
Korlym 36.3 Uterine Motility Drugs and Lactation Considerations
Kyleena 36.2 Hormonal, Contraception, and Infertility Drugs
Kytril 30.1 Antiemetics
L
Lacosamide 12.1 Epilepsy and Anticonvulsant Drugs
Lacri-Lube 38.3 Ocular Anesthetics and Lubricants
Lactation 4.4 Negative Feedback Loop, 36.3 Uterine Motility Drugs and Lactation Considerations
LactMed® database 36.3 Uterine Motility Drugs and Lactation Considerations
Lagevrio 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Lamictal 12.1 Epilepsy and Anticonvulsant Drugs , 13.3 Mood Stabilizers
Lamotrigine 12.1 Epilepsy and Anticonvulsant Drugs , 13.3 Mood Stabilizers
Langerhans cells 40.1 Introduction to the Skin and Its Function
Lanoxin 17.6 Unclassified Antidysrhythmics
Lanreotide acetate 26.2 Growth Hormones and Suppressants
Lansoprazole 31.2 Histamine Blockers and Proton-Pump Inhibitors
Lantus 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Laryngitis 23.1 Introduction to the Upper Respiratory System
Lasix 19.5 Diuretics, 34.2 Loop Diuretics
lasmiditan 12.2 Migraine Headaches and Migraine Headache Drugs
Latanaprost 0.005% solution 38.4 Antiglaucoma Drugs
Latino/Latina 28.1 Introduction to Diabetes, 28.1 Introduction to Diabetes
Latuda 13.2 Antipsychotics
Laxatives 29.3 Introduction to the Small and Large Intestines, 30.3 Laxatives and Stool Softeners
LDL-cholesterol 21.1 Introduction to Lipoprotein and Apolipoproteins
lecanemab-irmb 10.4 Alzheimer’s Drugs
Lemborexant 13.4 Anxiolytics and Sedative-Hypnotics
Lemtrada 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Leptin 32.1 Introduction to Weight Management
leptin resistance 32.1 Introduction to Weight Management
LEQEMBI 10.4 Alzheimer’s Drugs
Leqvio 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Lescol XL 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Lessina 36.2 Hormonal, Contraception, and Infertility Drugs
leukemia 8.1 Introduction to Cancer and Phases of Cancer Therapy
leukocytes 8.2 Chemotherapeutic Drugs
leukopenia 8.2 Chemotherapeutic Drugs
Leukotriene modifiers 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
leukotrienes 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Levalbuterol 25.1 Adrenergics and Anticholinergics
Levemir 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Levetiracetam 12.1 Epilepsy and Anticonvulsant Drugs
Levitra 36.7 Phosphodiesterase 5 Inhibitors
Levocetirizine 24.1 Antihistamines and Decongestants
Levodopa 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs
Levomilnacipran 13.1 Antidepressants
Levonorgestrel 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs
Levonorgestrel and ethinyl estradiol 36.2 Hormonal, Contraception, and Infertility Drugs
Levothyroxine sodium 27.2 Thyroid and Antithyroid Drugs
Levoxyl 27.2 Thyroid and Antithyroid Drugs
Lexapro 13.1 Antidepressants
Lhermitte sign 11.3 Introduction to Multiple Sclerosis
Librium 15.3 Alcohol Use Disorder Drugs
Licorice root 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Lidocaine 17.1 Introduction to Dysrhythmias, 17.2 Class I: Sodium Channel Blockers, 22.2 Cardiac Emergency Drugs
Life phase 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
ligand 2.2 Pharmacokinetics and Pharmacodynamics
Liletta 36.2 Hormonal, Contraception, and Infertility Drugs
Linaclotide 30.3 Laxatives and Stool Softeners
lincosamide antibiotic 40.2 Acne Drugs
Lincosamides 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Lindane 7.6 Antiparasitic and Anthelminthic Drugs
Linezolid 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Linzess 30.3 Laxatives and Stool Softeners
Lioresal 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Liothyronine sodium 27.2 Thyroid and Antithyroid Drugs
lipase 29.3 Introduction to the Small and Large Intestines, 32.3 Lipase Inhibitors
Lipase inhibitors 32.3 Lipase Inhibitors
Lipitor 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
lipoatrophy 11.4 Drugs Used in the Treatment of Multiple Sclerosis
lipoprotein lipase 21.1 Introduction to Lipoprotein and Apolipoproteins
Lipoproteins 21.1 Introduction to Lipoprotein and Apolipoproteins
Liraglutide 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs, 32.4 Other Drugs, Supplements, and Herbal Remedies
Liraglutide/insulin degludec 28.3 Oral Antidiabetic Drugs
Lisdexamfetamine 13.5 CNS Stimulants and Nonstimulants
Lisinopril 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
List of Confused Drug Names 3.2 Drug Errors and Prevention
Lithium 13.3 Mood Stabilizers
Livalo 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Live attenuated vaccines 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Lomaira 32.2 Anorexiants
Lomotil 30.2 Antidiarrheals
Lomustine 8.2 Chemotherapeutic Drugs
long-acting beta-2 agonist 25.1 Adrenergics and Anticholinergics
Long-acting insulin 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
loop diuretic dosing system 34.2 Loop Diuretics
Loop diuretics 19.5 Diuretics, 34.2 Loop Diuretics
loop of Henle 33.1 Introduction to the Renal System
Loperamide 30.2 Antidiarrheals
Lopid 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Lopressor 17.3 Class II: Beta Adrenergic Blockers, 18.4 Beta-Adrenergic Blockers
Loratadine 8.2 Chemotherapeutic Drugs, 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Lorazepam 12.1 Epilepsy and Anticonvulsant Drugs , 12.1 Epilepsy and Anticonvulsant Drugs , 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics, 15.3 Alcohol Use Disorder Drugs
Losartan 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Lotensin 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors
Lovastatin 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Lovaza 13.4 Anxiolytics and Sedative-Hypnotics
Lovenox 20.2 Anticoagulants, 20.2 Anticoagulants
Low-density lipoproteins (LDL or LDL-cholesterol) 21.1 Introduction to Lipoprotein and Apolipoproteins
lower esophageal sphincter 29.2 Introduction to the Esophagus and Stomach
lower respiratory system 23.2 Introduction to the Lower Respiratory System
loxitane 13.1 Antidepressants
Lozol 19.5 Diuretics
LubriTears 38.3 Ocular Anesthetics and Lubricants
Lukeran 8.2 Chemotherapeutic Drugs
lumateperone 13.3 Mood Stabilizers
Lumigan 38.4 Antiglaucoma Drugs
Lumryz 13.5 CNS Stimulants and Nonstimulants
Lunesta 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics
Lurasidone 13.2 Antipsychotics
Luteinizing hormone (LH) 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus, 36.1 Review of the Female Reproductive System
Lyrica 11.4 Drugs Used in the Treatment of Multiple Sclerosis
M
M-M-R-II 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Maalox 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Macrobid 35.1 Urinary Anti-infectives
Macrodantin 35.1 Urinary Anti-infectives
Macrolides 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
macrophages 11.3 Introduction to Multiple Sclerosis
Macular degeneration 38.1 Introduction to the Eyes
Mafenide acetate 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Magnesium (Mg) 5.2 Electrolytes
Magnesium citrate 30.3 Laxatives and Stool Softeners
Magnesium hydroxide 31.1 Antacids
Magnetic resonance imaging (MRI) 12.1 Epilepsy and Anticonvulsant Drugs
male reproductive system 36.5 Review of the Male Reproductive System
male-to-female (MTF) transition 37.2 Feminizing Hormonal Therapy
males 11.1 Introduction to Parkinson’s Disease
malleus 39.1 Introduction to the Ears
Mallory-Weis tears 24.3 Expectorants and Mucolytics
Management of cardiac dysrhythmias 17.1 Introduction to Dysrhythmias
Mannitol 12.3 Intracranial Emergencies and Intracranial Emergency Drugs, 34.3 Osmotic Diuretics
MAO-B inhibitors 11.2 Anti-Parkinsonian Drugs
Marinol 30.1 Antiemetics
Mast cell stabilizers 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Mast cells 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
mastication 29.1 Introduction to the Gastrointestinal System and Oral Cavity
Maxalt 12.2 Migraine Headaches and Migraine Headache Drugs
Maxidex 38.2 Ocular Anti-inflammatories and Anti-infectives
Mayzent 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Mean arterial pressure (MAP) 16.1 Introduction to the Heart, Circulation, and Blood Flow
Measles, mumps, and rubella (MMR) vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Mebendazole 7.6 Antiparasitic and Anthelminthic Drugs
mechanism of action 2.2 Pharmacokinetics and Pharmacodynamics
Meclizine 30.1 Antiemetics
medical cannabis 30.1 Antiemetics
medication administration 2.1 Drug Administration and the Nursing Process
medication administration record (MAR) 3.2 Drug Errors and Prevention
medication error 3.2 Drug Errors and Prevention
Medication reconciliation 2.1 Drug Administration and the Nursing Process
Medication safety 2.1 Drug Administration and the Nursing Process, 2.3 Drug Administration Routes, Preparation, and Administration, 3.2 Drug Errors and Prevention
Medications for IBS 29.3 Introduction to the Small and Large Intestines
Mediterranean diet 32.1 Introduction to Weight Management
Medrol 25.2 Corticosteroids, 26.4 Glucocorticoids and Mineralocorticoids, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Medroxyprogesterone 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs
MedWatch 1.2 Drug Sources, Forms, and Names, 3.2 Drug Errors and Prevention
Meloxicam 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Memantine 10.4 Alzheimer’s Drugs
membrane potential 16.3 Conduction of Electrical Impulses
menarche 36.1 Review of the Female Reproductive System
Ménière’s disease 39.1 Introduction to the Ears
Meningococcal group B vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Menopause 36.1 Review of the Female Reproductive System
Menopur 36.2 Hormonal, Contraception, and Infertility Drugs
Menotropin 36.2 Hormonal, Contraception, and Infertility Drugs
menstrual cycle 36.1 Review of the Female Reproductive System
Meperidine 14.3 Opioid Agonists and Antagonists
Mercaptopurine 8.2 Chemotherapeutic Drugs
mesangial cells 33.1 Introduction to the Renal System
Mesna 8.2 Chemotherapeutic Drugs
Mestinon 10.2 Cholinergic Drugs
metabolic syndrome 32.1 Introduction to Weight Management
metabolism 2.2 Pharmacokinetics and Pharmacodynamics, 29.1 Introduction to the Gastrointestinal System and Oral Cavity
metastasize Introduction
Metformin 28.3 Oral Antidiabetic Drugs, 28.3 Oral Antidiabetic Drugs
methadone 10.4 Alzheimer’s Drugs, 14.3 Opioid Agonists and Antagonists, 15.2 Opioid Use Disorder Drugs
Methamphetamine 13.5 CNS Stimulants and Nonstimulants, 24.1 Antihistamines and Decongestants
Methenamine hippurate 35.1 Urinary Anti-infectives, 35.1 Urinary Anti-infectives
Methergine 36.3 Uterine Motility Drugs and Lactation Considerations
Methimazole 27.2 Thyroid and Antithyroid Drugs
Methitest 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Methotrexate 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 8.2 Chemotherapeutic Drugs
Methoxsalen 40.3 Psoriatic Drugs
Methycellulose 30.3 Laxatives and Stool Softeners
Methylergonovine 36.3 Uterine Motility Drugs and Lactation Considerations
Methylphenidate 13.5 CNS Stimulants and Nonstimulants
Methylprednisolone 25.2 Corticosteroids, 26.4 Glucocorticoids and Mineralocorticoids, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Methyltestosterone 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Metolazone 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
Metoprolol 17.1 Introduction to Dysrhythmias, 17.3 Class II: Beta Adrenergic Blockers
Metoprolol succinate 19.3 Beta-Adrenergic Blockers
Metoprolol tartrate 18.4 Beta-Adrenergic Blockers
Metronidazole 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them, 7.6 Antiparasitic and Anthelminthic Drugs, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Mexiletine 17.1 Introduction to Dysrhythmias, 17.2 Class I: Sodium Channel Blockers
micafungin 39.1 Introduction to the Ears
Micardis 18.3 Angiotensin II Receptor Blockers (ARBs)
micrographia 11.1 Introduction to Parkinson’s Disease
microorganisms Introduction
microtubules 10.3 Introduction to Alzheimer’s Disease
Microvascular angina 18.1 Hypertension and Angina
Microzide 18.6 Diuretics, 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
Micturition 33.3 Introduction to the Urinary System
Midamor 18.6 Diuretics, 34.4 Potassium-Sparing Diuretics
Mifeprex 36.3 Uterine Motility Drugs and Lactation Considerations
Mifepristone 36.3 Uterine Motility Drugs and Lactation Considerations
Mifepristone REMS (Risk Evaluation and Mitigation Strategy) Program 36.3 Uterine Motility Drugs and Lactation Considerations
Miglitol 28.3 Oral Antidiabetic Drugs, 28.3 Oral Antidiabetic Drugs
migraine headaches 12.2 Migraine Headaches and Migraine Headache Drugs
Milk of Magnesia 31.1 Antacids
Milk thistle 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Millipred 26.4 Glucocorticoids and Mineralocorticoids
Mineral Oil 30.3 Laxatives and Stool Softeners
Mineralocorticoid receptor antagonists (MRAs) 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Mineralocorticoids 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus, 26.4 Glucocorticoids and Mineralocorticoids, 26.4 Glucocorticoids and Mineralocorticoids
minerals 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
minimum effective concentration (MEC) 2.2 Pharmacokinetics and Pharmacodynamics
Minocin 40.2 Acne Drugs
Minocycline hydrochloride 40.2 Acne Drugs
Mirabegron 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics, 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Miralax 30.3 Laxatives and Stool Softeners
Mirapex 11.2 Anti-Parkinsonian Drugs
Mircette 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs
Mirena 36.2 Hormonal, Contraception, and Infertility Drugs
Mirtazapine 13.1 Antidepressants
Misoprostol 31.3 Pepsin Inhibitors and Prostaglandin Analogues
Mitomycin 8.2 Chemotherapeutic Drugs
Mobic 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Modafinil 13.5 CNS Stimulants and Nonstimulants
Modecate 13.2 Antipsychotics
Modulation 14.1 Introduction to Pain
Molnupiravir 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
monoamine 13.1 Antidepressants
Monoamine oxidase inhibitors (MAOIs) 13.1 Antidepressants, 24.1 Antihistamines and Decongestants
monoamine oxidase-B inhibitors 11.2 Anti-Parkinsonian Drugs
monoclonal antibodies 1.2 Drug Sources, Forms, and Names, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 8.4 Biologic Response Modifiers, 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Monomethyl fumarate 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Monophasic contraceptive pills 36.2 Hormonal, Contraception, and Infertility Drugs
Monopril 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Montelukast 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Monurol 35.1 Urinary Anti-infectives
Morphine 14.3 Opioid Agonists and Antagonists, 22.2 Cardiac Emergency Drugs
Motpoly XR 12.1 Epilepsy and Anticonvulsant Drugs
Motrin 14.2 Nonopioid Analgesics
mRNA vaccines 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
MS Contin 14.3 Opioid Agonists and Antagonists
Mucolytics 24.3 Expectorants and Mucolytics
Mucomyst 24.3 Expectorants and Mucolytics
Mucosal Protectants 31.3 Pepsin Inhibitors and Prostaglandin Analogues
Mucositis 8.2 Chemotherapeutic Drugs
Multaq 17.4 Class III: Potassium Channel Blockers
multiple myeloma 8.1 Introduction to Cancer and Phases of Cancer Therapy
Multiple sclerosis 11.3 Introduction to Multiple Sclerosis
Multivitamins 32.1 Introduction to Weight Management
Mupirocin 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
muscarinic 24.1 Antihistamines and Decongestants
muscarinic antagonists 11.2 Anti-Parkinsonian Drugs
muscle 11.4 Drugs Used in the Treatment of Multiple Sclerosis
muscle relaxants 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Mutamycin 8.2 Chemotherapeutic Drugs
mutations 8.1 Introduction to Cancer and Phases of Cancer Therapy
Myambutol 7.5 Introduction to Tuberculosis and Antitubercular Drugs
Myasthenia gravis (MG) 10.1 Introduction to Myasthenia Gravis
Mycamine 39.1 Introduction to the Ears
Mycophenolate 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
myelin 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
myelin sheath 11.3 Introduction to Multiple Sclerosis
Myelosuppression 8.2 Chemotherapeutic Drugs
Myocardial contraction 16.3 Conduction of Electrical Impulses
myogenic response 33.1 Introduction to the Renal System
Myopia 38.1 Introduction to the Eyes
Myrbetriq 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
myxedema coma 27.1 Introduction to the Thyroid and Parathyroid
N
Na+K+ATPase pump 4.3 Maintaining Homeostasis
nadir 8.2 Chemotherapeutic Drugs
Nadolol 18.4 Beta-Adrenergic Blockers
Nalbuphine 14.3 Opioid Agonists and Antagonists
Naloxone 15.2 Opioid Use Disorder Drugs
Naloxone hydrochloride 14.3 Opioid Agonists and Antagonists
naloxone hydrochloride nasal spray 14.3 Opioid Agonists and Antagonists
Naltrexone 15.2 Opioid Use Disorder Drugs
Naltrexone hydrochloride 14.3 Opioid Agonists and Antagonists
Namenda 10.4 Alzheimer’s Drugs
Namzaric 10.4 Alzheimer’s Drugs
Naprosyn 14.2 Nonopioid Analgesics
Naproxen sodium 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 14.2 Nonopioid Analgesics
Narcan 14.3 Opioid Agonists and Antagonists, 15.2 Opioid Use Disorder Drugs
NARCS U 14.3 Opioid Agonists and Antagonists
Nardil 13.1 Antidepressants
Nasal decongestants 24.1 Antihistamines and Decongestants
Nasal sprays 2.3 Drug Administration Routes, Preparation, and Administration
Natacyn 38.2 Ocular Anti-inflammatories and Anti-infectives
Natalizumab 11.4 Drugs Used in the Treatment of Multiple Sclerosis
natamycin 38.2 Ocular Anti-inflammatories and Anti-infectives
National Association of Pharmacy Regulatory Authorities (NAPRA) 1.2 Drug Sources, Forms, and Names
National Cancer Institute Introduction
National Council Licensure Examination (NCLEX) 1.2 Drug Sources, Forms, and Names
National Council Licensure Examination [NCLEX] 3.1 Legal Considerations
National Council of State Boards of Nursing (NCSBN) 2.1 Drug Administration and the Nursing Process
National Diabetes Prevention Program 28.1 Introduction to Diabetes
National Formulary (NF) 3.1 Legal Considerations
National Heart, Lung, and Blood Institute 16.1 Introduction to the Heart, Circulation, and Blood Flow, 16.2 Pumping Action of the Heart, 16.3 Conduction of Electrical Impulses
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 32.1 Introduction to Weight Management
National Institutes of Health (NIH) 32.2 Anorexiants
National Kidney Foundation 33.1 Introduction to the Renal System
National Neurological Conditions Surveillance System Introduction
Natroba 7.6 Antiparasitic and Anthelminthic Drugs
Natural immunity 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
natural lipase inhibitors 32.3 Lipase Inhibitors
Nebivolol 17.1 Introduction to Dysrhythmias
Needle Disposal 2.3 Drug Administration Routes, Preparation, and Administration
negative feedback 4.4 Negative Feedback Loop
Neoadjuvant therapy 8.2 Chemotherapeutic Drugs
neoangiogenesis 8.1 Introduction to Cancer and Phases of Cancer Therapy
neomycin and polymyxin B sulfates, and hydrocortisone otic solution 39.2 Otic Anti-inflammatories and Anti-infectives
Neomycin sulfate 38.2 Ocular Anti-inflammatories and Anti-infectives
Neostigmine 10.2 Cholinergic Drugs
nephrolithiasis 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
nephrons 33.1 Introduction to the Renal System
Nephrotic syndrome 33.1 Introduction to the Renal System, 34.1 Introduction to Diuretics
nervous system 9.1 Introduction to the Nervous System
netarsudil 38.4 Antiglaucoma Drugs
Neulasta 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 8.2 Chemotherapeutic Drugs, 13.4 Anxiolytics and Sedative-Hypnotics
Neupogen 8.2 Chemotherapeutic Drugs
Neupro 11.2 Anti-Parkinsonian Drugs
neuroadaptation 15.1 Introduction to Substance Use Disorders
neuroendocrine system 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
neurohypophysis 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
neuroleptic malignant syndrome (NMS) 11.2 Anti-Parkinsonian Drugs
Neurologic assessment 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Neurological disorders Introduction
neurons 9.2 Structure and Function of the Nervous System
Neurontin 11.4 Drugs Used in the Treatment of Multiple Sclerosis, 12.1 Epilepsy and Anticonvulsant Drugs
neuropathic pain 11.3 Introduction to Multiple Sclerosis, 14.1 Introduction to Pain
neuroplasticity 10.3 Introduction to Alzheimer’s Disease
neurotoxic 10.3 Introduction to Alzheimer’s Disease
neurotransmission 9.2 Structure and Function of the Nervous System
Neurotransmitters 9.2 Structure and Function of the Nervous System
Neutropenia 8.2 Chemotherapeutic Drugs, 31.2 Histamine Blockers and Proton-Pump Inhibitors
neutrophils 8.2 Chemotherapeutic Drugs
Nexium 31.2 Histamine Blockers and Proton-Pump Inhibitors
Next Generation National Council Licensure Examination (NGN) model 2.1 Drug Administration and the Nursing Process
Nexterone 17.4 Class III: Potassium Channel Blockers
Niacin 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Nicardipine 18.5 Calcium Channel Blockers
NicoDerm/Nicorette 15.4 Nicotine Use Disorder Drugs
Nicotine 15.4 Nicotine Use Disorder Drugs, 15.4 Nicotine Use Disorder Drugs
nicotine receptor agonist 15.4 Nicotine Use Disorder Drugs
nicotine withdrawal 15.4 Nicotine Use Disorder Drugs
Nifedipine 18.5 Calcium Channel Blockers
Nipride 18.7 Nitrates
Nirmatrelvir/ritonavir 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Nitazoxanide 7.6 Antiparasitic and Anthelminthic Drugs
nitrate 22.2 Cardiac Emergency Drugs
Nitrates 18.7 Nitrates
Nitrobid 18.7 Nitrates
Nitrofurantoin 35.1 Urinary Anti-infectives, 35.1 Urinary Anti-infectives
Nitrogen Mustards 8.2 Chemotherapeutic Drugs
Nitroglycerin 18.7 Nitrates, 22.2 Cardiac Emergency Drugs
nitroimidazoles 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Nitrolingual 18.7 Nitrates
Nitroprusside 18.7 Nitrates
Nitrosoureas 8.2 Chemotherapeutic Drugs
Nitrostat 18.7 Nitrates
Nivolumab 8.4 Biologic Response Modifiers
Nizatidine 31.2 Histamine Blockers and Proton-Pump Inhibitors
NMDA receptor antagonists 10.4 Alzheimer’s Drugs
Nociception 14.1 Introduction to Pain
Nociceptive pain 14.1 Introduction to Pain
nociceptors 14.1 Introduction to Pain
nocturia 34.1 Introduction to Diuretics
Nolvadex 8.3 Hormonal Therapy
Non-biologic DMARDs 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
non-Hispanic Asian adults 32.1 Introduction to Weight Management
Non-Hispanic Black adults 32.1 Introduction to Weight Management
non-Hispanic White adults 32.1 Introduction to Weight Management
non-Hodgkin lymphoma 8.1 Introduction to Cancer and Phases of Cancer Therapy
non-insulin injectable diabetes drugs Introduction
Non-insulin injectable drugs 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs, 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
non-nucleoside reverse transcriptase inhibitors (NNRTIs) 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Non-sulfonylurea biguanides 28.3 Oral Antidiabetic Drugs
nonbarbiturate anesthetic 38.2 Ocular Anti-inflammatories and Anti-infectives
nonbenzodiazepine sedative-hypnotics 13.4 Anxiolytics and Sedative-Hypnotics
Nonbinary 37.1 Overview of Transgender and Nonbinary Health
nonergot derivatives 11.2 Anti-Parkinsonian Drugs
nonmaleficence 3.2 Drug Errors and Prevention
nonopioid analgesic 14.2 Nonopioid Analgesics
Nonopioid antitussives 24.2 Antitussives
Nonpharmacologic management of dysrhythmias 17.1 Introduction to Dysrhythmias
nonselective alpha- and beta-adrenergic agonist 25.1 Adrenergics and Anticholinergics
nonsteroidal anti-inflammatory drugs (NSAIDs) 14.2 Nonopioid Analgesics, 38.2 Ocular Anti-inflammatories and Anti-infectives
Norepinephrine 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 9.3 Characteristics of Drugs to Treat Nervous System Disorders, Introduction, 22.3 Shock Drugs, 25.1 Adrenergics and Anticholinergics
Norepinephrine dopamine reuptake inhibitors (NDRIs) 13.1 Antidepressants
Norethindrone 36.2 Hormonal, Contraception, and Infertility Drugs
Norethindrone acetate 36.2 Hormonal, Contraception, and Infertility Drugs
Norphyl 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Norvasc 18.5 Calcium Channel Blockers
Novolin N 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Novolin R 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Novolog 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
NSAIDs 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 22.2 Cardiac Emergency Drugs
Nubain 14.3 Opioid Agonists and Antagonists
nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) 7.3 Introduction to HIV, AIDS, and Antiretrovirals
nurse practice act (NPA) 3.1 Legal Considerations
nursing informatics 3.3 Documentation and Informatics
nursing process 2.1 Drug Administration and the Nursing Process
Nurtec 12.2 Migraine Headaches and Migraine Headache Drugs
nutrient-dense foods 32.1 Introduction to Weight Management
Nutritional status 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
nystagmus 11.3 Introduction to Multiple Sclerosis
Nystat 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Nystatin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
O
Obamacare 3.1 Legal Considerations
obesity 32.1 Introduction to Weight Management
obesity and mental health 32.1 Introduction to Weight Management
obesity hypoventilation syndrome 32.1 Introduction to Weight Management
Obstructive shock 22.1 Introduction to Cardiac Emergencies and Shock
Ocrelizumab 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Ocrevus 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Octreotide 30.2 Antidiarrheals
Octreotide acetate 26.2 Growth Hormones and Suppressants
Ocu-Caine 38.3 Ocular Anesthetics and Lubricants
ocular anesthetics 38.3 Ocular Anesthetics and Lubricants
ocular antibacterials 38.2 Ocular Anti-inflammatories and Anti-infectives
ocular antifungals 38.2 Ocular Anti-inflammatories and Anti-infectives
ocular antivirals 38.2 Ocular Anti-inflammatories and Anti-infectives
ocular corticosteroids 38.2 Ocular Anti-inflammatories and Anti-infectives
ocular immunosuppressants 38.2 Ocular Anti-inflammatories and Anti-infectives
ocular NSAID 38.2 Ocular Anti-inflammatories and Anti-infectives
Ocupress 38.4 Antiglaucoma Drugs
Off-label prescription drug use 1.2 Drug Sources, Forms, and Names, 17.1 Introduction to Dysrhythmias
Ofloxacin 39.2 Otic Anti-inflammatories and Anti-infectives
Olanzapine 13.2 Antipsychotics, 13.2 Antipsychotics
Older adults 1.4 Special Considerations, 4.1 What Is Homeostasis?, 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 10.3 Introduction to Alzheimer’s Disease, 11.1 Introduction to Parkinson’s Disease, 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs , 13.1 Antidepressants, 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics, 14.2 Nonopioid Analgesics, 14.3 Opioid Agonists and Antagonists, 15.3 Alcohol Use Disorder Drugs, 17.1 Introduction to Dysrhythmias, 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 24.2 Antitussives , 25.1 Adrenergics and Anticholinergics, 29.1 Introduction to the Gastrointestinal System and Oral Cavity, 30.1 Antiemetics, 30.1 Antiemetics, 34.2 Loop Diuretics, 34.2 Loop Diuretics, 38.1 Introduction to the Eyes, 38.4 Antiglaucoma Drugs, 39.1 Introduction to the Ears, 39.1 Introduction to the Ears
older clients 14.3 Opioid Agonists and Antagonists, 19.1 Heart Failure, 24.1 Antihistamines and Decongestants, 31.2 Histamine Blockers and Proton-Pump Inhibitors, 32.1 Introduction to Weight Management, 35.1 Urinary Anti-infectives, 36.6 Androgens, Antiandrogens, and Anabolic Steroids, 36.6 Androgens, Antiandrogens, and Anabolic Steroids
older males 10.1 Introduction to Myasthenia Gravis
olfactory 23.1 Introduction to the Upper Respiratory System
oligodendrocytes 11.3 Introduction to Multiple Sclerosis
omega-3 acid ethyl esters 13.4 Anxiolytics and Sedative-Hypnotics
Omega-3 fatty acids 21.1 Introduction to Lipoprotein and Apolipoproteins
Omeprazole 31.2 Histamine Blockers and Proton-Pump Inhibitors
Omnicef 39.2 Otic Anti-inflammatories and Anti-infectives
Omnipred 26.4 Glucocorticoids and Mineralocorticoids, 38.2 Ocular Anti-inflammatories and Anti-infectives
oncogenes 8.1 Introduction to Cancer and Phases of Cancer Therapy
Oncology Nursing Society 8.2 Chemotherapeutic Drugs
Oncovin 8.2 Chemotherapeutic Drugs
Ondansetron 30.1 Antiemetics
onset of 2.2 Pharmacokinetics and Pharmacodynamics
Opdivo 8.4 Biologic Response Modifiers
open-angle glaucoma 38.1 Introduction to the Eyes
Ophthalmic steroids 38.2 Ocular Anti-inflammatories and Anti-infectives
Ophthalmologic examination 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Opioid agonist 14.3 Opioid Agonists and Antagonists, 22.2 Cardiac Emergency Drugs
Opioid Analgesics 22.2 Cardiac Emergency Drugs
opioid antagonist 14.3 Opioid Agonists and Antagonists, 32.4 Other Drugs, Supplements, and Herbal Remedies
Opioid antitussives 24.2 Antitussives
Opioid intoxication 15.2 Opioid Use Disorder Drugs
opioid receptor antagonist 15.2 Opioid Use Disorder Drugs
opioid use disorder 14.3 Opioid Agonists and Antagonists
Opioid withdrawal 15.2 Opioid Use Disorder Drugs
Opioid-Related Antidiarrheal Medications 30.2 Antidiarrheals
Opioids 14.3 Opioid Agonists and Antagonists, 15.2 Opioid Use Disorder Drugs
Oral administration 2.3 Drug Administration Routes, Preparation, and Administration
oral anticoagulants 20.2 Anticoagulants
oral diabetes drugs Introduction
Orbital cellulitis 38.1 Introduction to the Eyes
organification 27.2 Thyroid and Antithyroid Drugs
Orlistat 32.3 Lipase Inhibitors
Ortho Micronor 36.2 Hormonal, Contraception, and Infertility Drugs
Ortho-Est 36.2 Hormonal, Contraception, and Infertility Drugs
Oseltamivir 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Osmolality 4.2 Osmolality
osmole 4.2 Osmolality
osmosis 4.1 What Is Homeostasis?
Osmotic diuretics 12.3 Intracranial Emergencies and Intracranial Emergency Drugs, 34.3 Osmotic Diuretics
Osmotic equilibrium 4.3 Maintaining Homeostasis
osmotic pressure 4.1 What Is Homeostasis?
ossicles 39.1 Introduction to the Ears
osteoclasts 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
osteonecrosis 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Osteopenia 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
osteoporosis 27.1 Introduction to the Thyroid and Parathyroid, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Other Anthracyclines 8.2 Chemotherapeutic Drugs
otic anti-inflammatories 39.2 Otic Anti-inflammatories and Anti-infectives
otic cerumenolytics 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
otic systemic anti-infectives 39.2 Otic Anti-inflammatories and Anti-infectives
otic topical anti-infectives 39.2 Otic Anti-inflammatories and Anti-infectives
Otitis externa 39.1 Introduction to the Ears
Otitis media 39.1 Introduction to the Ears
otoliths 39.1 Introduction to the Ears
ototoxicity 34.2 Loop Diuretics
ovarian reproductive system 36.1 Review of the Female Reproductive System
Over-the-counter (OTC) drugs 1.2 Drug Sources, Forms, and Names
Overdose 12.1 Epilepsy and Anticonvulsant Drugs
Overweight 32.1 Introduction to Weight Management
Ovidrel 36.2 Hormonal, Contraception, and Infertility Drugs
ox bile supplements 32.3 Lipase Inhibitors
Oxaliplatin 8.2 Chemotherapeutic Drugs
oxandrolone 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Oxazolidinones 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Oxicams 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Oxsoralen 40.3 Psoriatic Drugs
Oxybutynin chloride 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics, 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Oxycodone 14.3 Opioid Agonists and Antagonists
OxyContin 14.3 Opioid Agonists and Antagonists
oxygen 22.2 Cardiac Emergency Drugs
oxygen saturation 22.2 Cardiac Emergency Drugs
Oxygenation 23.3 Oxygenation and Gas Exchange
oxytocics 36.3 Uterine Motility Drugs and Lactation Considerations, 36.3 Uterine Motility Drugs and Lactation Considerations
Oxytocin 36.3 Uterine Motility Drugs and Lactation Considerations
Oxytrol 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
P
P2Y12 inhibitors 20.3 Antiplatelets
Pacerone 17.4 Class III: Potassium Channel Blockers
Packed red blood cells (PRBCs) 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Paclitaxel 8.2 Chemotherapeutic Drugs
Paget’s disease 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Pain 14.1 Introduction to Pain
pain assessment 14.1 Introduction to Pain
pain threshold 14.1 Introduction to Pain
Paliperidone 13.2 Antipsychotics
Pan American Health Organization (PAHO) Introduction
Pancreatin 30.2 Antidiarrheals
Pancrelipase 30.2 Antidiarrheals
pancytopenia 8.2 Chemotherapeutic Drugs
Panmycin 40.2 Acne Drugs
pantoprazole 13.2 Antipsychotics, 31.2 Histamine Blockers and Proton-Pump Inhibitors
papillae 40.1 Introduction to the Skin and Its Function
paradoxical medication effects 13.4 Anxiolytics and Sedative-Hypnotics
Paraplatin 8.2 Chemotherapeutic Drugs
parasitic infections 7.6 Antiparasitic and Anthelminthic Drugs
parasomnias 13.5 CNS Stimulants and Nonstimulants
parasympathetic nervous system 9.2 Structure and Function of the Nervous System, Introduction
parasympatholytics 10.2 Cholinergic Drugs, 11.2 Anti-Parkinsonian Drugs
parasympathomimetic 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 10.2 Cholinergic Drugs
parathyroid hormone (PTH) 27.1 Introduction to the Thyroid and Parathyroid
Parcopa 11.2 Anti-Parkinsonian Drugs
parenteral 2.3 Drug Administration Routes, Preparation, and Administration
Parenteral administration 1.2 Drug Sources, Forms, and Names, 2.3 Drug Administration Routes, Preparation, and Administration
parenteral medication 2.3 Drug Administration Routes, Preparation, and Administration
parenteral route 1.2 Drug Sources, Forms, and Names
Parkinson’s disease (PD) 11.1 Introduction to Parkinson’s Disease
Parlodel 11.2 Anti-Parkinsonian Drugs , 26.2 Growth Hormones and Suppressants
Paroxetine 13.1 Antidepressants
partial agonists 2.2 Pharmacokinetics and Pharmacodynamics
partial mu opioid receptor agonist 15.2 Opioid Use Disorder Drugs
partial seizures 12.1 Epilepsy and Anticonvulsant Drugs
Partial thromboplastin time (PTT) 20.2 Anticoagulants
Passive immunity 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Pathophysiology 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
Paxil 13.1 Antidepressants, 13.1 Antidepressants
Paxlovid 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
PCSK9 inhibitors 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
PD-1 Inhibitors 8.4 Biologic Response Modifiers
peak 2.2 Pharmacokinetics and Pharmacodynamics
Peak time 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
pediatric 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice , 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations, 26.2 Growth Hormones and Suppressants, 26.2 Growth Hormones and Suppressants, 35.1 Urinary Anti-infectives
pediatric clients 2.4 Dosage Calculations, 2.4 Dosage Calculations, 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 12.1 Epilepsy and Anticonvulsant Drugs , 12.1 Epilepsy and Anticonvulsant Drugs , 13.1 Antidepressants, 13.1 Antidepressants, 13.2 Antipsychotics, 13.2 Antipsychotics, 13.2 Antipsychotics, 13.3 Mood Stabilizers, 13.4 Anxiolytics and Sedative-Hypnotics, 13.5 CNS Stimulants and Nonstimulants, 13.5 CNS Stimulants and Nonstimulants, 14.2 Nonopioid Analgesics, 17.1 Introduction to Dysrhythmias, 20.3 Antiplatelets, 21.3 Bile Acid Sequestrants, Fibrates, and Niacin, 22.2 Cardiac Emergency Drugs, 25.1 Adrenergics and Anticholinergics, 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 30.1 Antiemetics, 30.1 Antiemetics, 30.1 Antiemetics, 38.1 Introduction to the Eyes, 39.2 Otic Anti-inflammatories and Anti-infectives, 39.2 Otic Anti-inflammatories and Anti-infectives, 39.2 Otic Anti-inflammatories and Anti-infectives, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics, 40.2 Acne Drugs, 40.2 Acne Drugs, 40.3 Psoriatic Drugs, 40.3 Psoriatic Drugs, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
pediatric dosage 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 12.1 Epilepsy and Anticonvulsant Drugs , 12.1 Epilepsy and Anticonvulsant Drugs , 12.1 Epilepsy and Anticonvulsant Drugs , 12.1 Epilepsy and Anticonvulsant Drugs , 12.1 Epilepsy and Anticonvulsant Drugs , 13.1 Antidepressants, 13.1 Antidepressants, 13.1 Antidepressants, 13.2 Antipsychotics, 13.2 Antipsychotics, 13.4 Anxiolytics and Sedative-Hypnotics, 13.5 CNS Stimulants and Nonstimulants, 13.5 CNS Stimulants and Nonstimulants, 14.2 Nonopioid Analgesics, 24.3 Expectorants and Mucolytics, 25.1 Adrenergics and Anticholinergics, 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 28.3 Oral Antidiabetic Drugs, 39.2 Otic Anti-inflammatories and Anti-infectives, 39.2 Otic Anti-inflammatories and Anti-infectives, 39.2 Otic Anti-inflammatories and Anti-infectives, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics, 40.2 Acne Drugs, 40.2 Acne Drugs, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Pediatric dosing 1.4 Special Considerations, 28.3 Oral Antidiabetic Drugs, 28.3 Oral Antidiabetic Drugs
pediatric exception note for metformin 28.3 Oral Antidiabetic Drugs
pediatric exposures 15.4 Nicotine Use Disorder Drugs
Pediatric Pharmacy Association 1.4 Special Considerations
pediatric population 2.1 Drug Administration and the Nursing Process
pediatric setting 2.4 Dosage Calculations
Pegfilgrastim 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 8.2 Chemotherapeutic Drugs
Pegvisomant 26.2 Growth Hormones and Suppressants
Pembrolizumab 8.4 Biologic Response Modifiers
Pemetrexed 8.2 Chemotherapeutic Drugs
Penicillamine 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Penicillin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Penicillin G benzathine 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
people of color (POC) 1.2 Drug Sources, Forms, and Names
Pepcid 31.2 Histamine Blockers and Proton-Pump Inhibitors
pepsin 29.1 Introduction to the Gastrointestinal System and Oral Cavity, 31.2 Histamine Blockers and Proton-Pump Inhibitors
Pepsin inhibitors/mucosal protectants 29.3 Introduction to the Small and Large Intestines
pepsinogen 29.2 Introduction to the Esophagus and Stomach
peptic ulcer disease (PUD) Introduction
Peptide hormones 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Pepto Bismol 30.2 Antidiarrheals
perception 14.1 Introduction to Pain
Percutaneous administration 1.2 Drug Sources, Forms, and Names, 2.3 Drug Administration Routes, Preparation, and Administration
Perfusion 23.3 Oxygenation and Gas Exchange
perimenopause 36.1 Review of the Female Reproductive System
peripheral nervous system (PNS) 9.2 Structure and Function of the Nervous System, Introduction
peripheral vascular resistance 18.1 Hypertension and Angina
peristalsis 29.1 Introduction to the Gastrointestinal System and Oral Cavity
Permethrin 7.6 Antiparasitic and Anthelminthic Drugs
petit mal seizures 12.1 Epilepsy and Anticonvulsant Drugs
pharmacodynamics 2.2 Pharmacokinetics and Pharmacodynamics
pharmacoeconomics 1.4 Special Considerations
pharmacogenetics 1.4 Special Considerations
Pharmacokinetics 1.4 Special Considerations, 2.2 Pharmacokinetics and Pharmacodynamics
Pharmacologic classification 1.3 Drug Classifications and Prototypes
pharmacology 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
Pharyngitis 23.1 Introduction to the Upper Respiratory System
Phenazopyridine hydrochloride 35.3 Urinary Analgesics
Phendimetrazine 32.2 Anorexiants
Phenelzine sulfate 13.1 Antidepressants
Phenergan 30.1 Antiemetics
Phenobarbital 12.1 Epilepsy and Anticonvulsant Drugs
Phenothiazines 30.1 Antiemetics
Phentermine 32.2 Anorexiants
Phentermine and topiramate ER 32.2 Anorexiants
Phenylacetic acid derivatives 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Phenylephrine 24.1 Antihistamines and Decongestants
Phenytoin 12.1 Epilepsy and Anticonvulsant Drugs
pheochromocytoma 28.3 Oral Antidiabetic Drugs
PhosLo 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Phosphodiesterase 5 (PDE5) inhibitors 35.5 Phosphodiesterase 5 Inhibitors, 36.7 Phosphodiesterase 5 Inhibitors
Phosphorous (P) 5.2 Electrolytes
photophobia 38.1 Introduction to the Eyes
photosensitivity 35.1 Urinary Anti-infectives
Phyllocontin 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Physical dependence 15.1 Introduction to Substance Use Disorders
Pimecrolimus 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Pioglitazone 28.3 Oral Antidiabetic Drugs
Piroxicam 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Pitavastatin 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Pitocin 36.3 Uterine Motility Drugs and Lactation Considerations
Pitolisant 13.5 CNS Stimulants and Nonstimulants
pituitary gland 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
Plan B One-Step 36.2 Hormonal, Contraception, and Infertility Drugs
Planning 2.1 Drug Administration and the Nursing Process
plant alkaloids 8.2 Chemotherapeutic Drugs
Plaquenil 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
plaques 11.3 Introduction to Multiple Sclerosis, 40.3 Psoriatic Drugs
Platelets 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products, Introduction
Plavix 13.1 Antidepressants, 20.3 Antiplatelets
pleiotropic effects 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Pneumococcal 13-variant vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Pneumococcal polyvarent vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Pneumovax 23 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Polyderm 40.3 Psoriatic Drugs
polydipsia 28.1 Introduction to Diabetes
Polyenes 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Polyethylene glycol 30.3 Laxatives and Stool Softeners
polyphagia 28.1 Introduction to Diabetes
polyuria 28.1 Introduction to Diabetes
Pontocaine 38.3 Ocular Anesthetics and Lubricants
positive feedback 4.4 Negative Feedback Loop
Positron emission tomography (PET) scan 12.1 Epilepsy and Anticonvulsant Drugs
postganglionic neurons 10.2 Cholinergic Drugs
postmenopausal clients 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.2 Hormonal, Contraception, and Infertility Drugs
Potassium (K) 5.2 Electrolytes
Potassium channel blockers 17.1 Introduction to Dysrhythmias, 17.4 Class III: Potassium Channel Blockers
Potassium iodide 27.2 Thyroid and Antithyroid Drugs
potassium supplements 5.2 Electrolytes
potassium-binding drugs 5.2 Electrolytes
potassium-sparing diuretics 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 34.4 Potassium-Sparing Diuretics
Pradaxa 20.2 Anticoagulants
Prader-Willi syndrome 26.2 Growth Hormones and Suppressants
pralidoxime 10.2 Cholinergic Drugs
Praluent 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Pramipexole 11.2 Anti-Parkinsonian Drugs
Pramlintide 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Prandin 28.3 Oral Antidiabetic Drugs
Prasugrel 20.3 Antiplatelets
Pravachol 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Pravastatin 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Precose 28.3 Oral Antidiabetic Drugs
prediabetes 28.1 Introduction to Diabetes
Prednicot 25.2 Corticosteroids
Prednisolone 26.4 Glucocorticoids and Mineralocorticoids
Prednisolone sodium phosphate 38.2 Ocular Anti-inflammatories and Anti-infectives
Prednisone 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 25.2 Corticosteroids, 26.4 Glucocorticoids and Mineralocorticoids
Pregabalin 11.4 Drugs Used in the Treatment of Multiple Sclerosis
preganglionic neurons 10.2 Cholinergic Drugs
pregnancy 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice , 4.1 What Is Homeostasis?, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 36.1 Review of the Female Reproductive System
Pregnancy and lactation 1.4 Special Considerations
Preload 16.2 Pumping Action of the Heart, 19.1 Heart Failure
Prelone 26.4 Glucocorticoids and Mineralocorticoids
premature ventricular contraction (PVC) 17.1 Introduction to Dysrhythmias
Presbyopia 38.1 Introduction to the Eyes
Prescription medications 1.2 Drug Sources, Forms, and Names
Prevacid 31.2 Histamine Blockers and Proton-Pump Inhibitors
preventive therapy 12.2 Migraine Headaches and Migraine Headache Drugs
Prevnar 13 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Prilosec 13.1 Antidepressants, 31.2 Histamine Blockers and Proton-Pump Inhibitors
primary open-angle glaucoma (POAG) 38.4 Antiglaucoma Drugs
Primatene Mist 25.1 Adrenergics and Anticholinergics
proarrhythmia 17.2 Class I: Sodium Channel Blockers
Probalan 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Probenecid 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Procainamide 17.1 Introduction to Dysrhythmias, 17.2 Class I: Sodium Channel Blockers, 22.2 Cardiac Emergency Drugs
Procardia 18.5 Calcium Channel Blockers
Prochlorperazine 30.1 Antiemetics
Proctocort 26.4 Glucocorticoids and Mineralocorticoids
prodrug 13.5 CNS Stimulants and Nonstimulants
progesterone 36.1 Review of the Female Reproductive System
Progestin-only contraceptives 36.2 Hormonal, Contraception, and Infertility Drugs
Progestins 36.2 Hormonal, Contraception, and Infertility Drugs
Prograf 13.1 Antidepressants
Prolactin (PRL) 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
proliferating 11.3 Introduction to Multiple Sclerosis
Prolixin 13.2 Antipsychotics
Promethazine 30.1 Antiemetics
Propafenone 17.1 Introduction to Dysrhythmias, 17.2 Class I: Sodium Channel Blockers
Proparacaine 38.3 Ocular Anesthetics and Lubricants
Propecia 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Propionic acid derivatives 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Propranolol 17.3 Class II: Beta Adrenergic Blockers, 18.4 Beta-Adrenergic Blockers
Propylthiouracil 27.2 Thyroid and Antithyroid Drugs
Proscar 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Prostaglandin analogues 38.4 Antiglaucoma Drugs, 38.4 Antiglaucoma Drugs
Prostaglandin-E analogs 29.3 Introduction to the Small and Large Intestines
Prostaglandins 31.3 Pepsin Inhibitors and Prostaglandin Analogues
Prostera 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Protamine 20.2 Anticoagulants
protease 29.3 Introduction to the Small and Large Intestines
protease inhibitors 7.3 Introduction to HIV, AIDS, and Antiretrovirals
protected health information (PHI) 3.1 Legal Considerations
prothrombin time (PT) 20.2 Anticoagulants
proton pump inhibitor 13.2 Antipsychotics, 29.3 Introduction to the Small and Large Intestines, 31.2 Histamine Blockers and Proton-Pump Inhibitors
Protonix 31.2 Histamine Blockers and Proton-Pump Inhibitors
Protozoa 7.6 Antiparasitic and Anthelminthic Drugs
Proventil 25.1 Adrenergics and Anticholinergics
Provera 13.1 Antidepressants, 36.2 Hormonal, Contraception, and Infertility Drugs, 36.2 Hormonal, Contraception, and Infertility Drugs
Provigil 13.5 CNS Stimulants and Nonstimulants
Prozac 13.1 Antidepressants, 13.1 Antidepressants
Pseudoephedrine 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
pseudoparkinsonism 13.2 Antipsychotics
Psoriasis 40.3 Psoriatic Drugs
Psoriderm 40.3 Psoriatic Drugs
psychologic impact of acne 40.2 Acne Drugs
psychological dependence 15.1 Introduction to Substance Use Disorders
psychomotor domain 2.1 Drug Administration and the Nursing Process
Psychopharmacology Introduction
Psychosis 13.2 Antipsychotics
psychotropic medications Introduction
Psyllium 30.3 Laxatives and Stool Softeners
Ptosis 10.1 Introduction to Myasthenia Gravis
PTU 27.2 Thyroid and Antithyroid Drugs
Pulmicort 25.2 Corticosteroids
pulmonary arteries 16.1 Introduction to the Heart, Circulation, and Blood Flow
pulmonary edema 22.1 Introduction to Cardiac Emergencies and Shock
pulmonary embolism (PE) 20.1 Introduction to Clotting and Coagulation
pulmonary fibrosis Introduction
Pulmonary function tests (PFTs) 23.2 Introduction to the Lower Respiratory System
pulmonary toxicity 8.2 Chemotherapeutic Drugs
pulmonary veins 16.1 Introduction to the Heart, Circulation, and Blood Flow
Pulmozyme 24.3 Expectorants and Mucolytics
pulseless electrical activity 17.1 Introduction to Dysrhythmias, 22.2 Cardiac Emergency Drugs
Pulseless ventricular tachycardia 22.2 Cardiac Emergency Drugs
Purine Antimetabolites 8.2 Chemotherapeutic Drugs
Purixan 8.2 Chemotherapeutic Drugs
Purkinje fibers 16.3 Conduction of Electrical Impulses
pyelonephritis 33.1 Introduction to the Renal System
Pyrazinamide 7.5 Introduction to Tuberculosis and Antitubercular Drugs
Pyridostigmine bromide 10.2 Cholinergic Drugs
Pyrimidine Antimetabolites 8.2 Chemotherapeutic Drugs
Pyrrolidine derivatives 12.1 Epilepsy and Anticonvulsant Drugs
Q
Qelbree 13.5 CNS Stimulants and Nonstimulants
Qsymia 32.2 Anorexiants
Quality and Safety Education for Nurses (QSEN) initiative 3.3 Documentation and Informatics
Qudexy 12.1 Epilepsy and Anticonvulsant Drugs
Questran 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Quetiapine 13.2 Antipsychotics, 13.2 Antipsychotics
Quibron-T 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
quick start method 36.2 Hormonal, Contraception, and Infertility Drugs
Quinapril 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Quinidine 17.1 Introduction to Dysrhythmias, 17.2 Class I: Sodium Channel Blockers
Quviviq 13.4 Anxiolytics and Sedative-Hypnotics
Qvar 25.2 Corticosteroids
R
Race and ethnicity 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
racial and ethnic minorities 1.2 Drug Sources, Forms, and Names, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Radiologic imaging 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
raloxifene 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Raltegravir 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Ramelteon 13.4 Anxiolytics and Sedative-Hypnotics
random blood glucose 28.1 Introduction to Diabetes
Rapaflo 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Rapid-acting insulin 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Rasagiline 11.2 Anti-Parkinsonian Drugs
rasburicase 8.1 Introduction to Cancer and Phases of Cancer Therapy
ratio and proportion method 2.4 Dosage Calculations
Razadyne 10.4 Alzheimer’s Drugs, 13.4 Anxiolytics and Sedative-Hypnotics
rebound congestion 24.1 Antihistamines and Decongestants
rebound hyperacidity 31.1 Antacids
receptor 2.2 Pharmacokinetics and Pharmacodynamics, 4.1 What Is Homeostasis?
Reclast 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Recombinant vaccines 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Recombivax HB 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
rectal administration 2.3 Drug Administration Routes, Preparation, and Administration
referred pain 14.1 Introduction to Pain
Refractive errors 38.1 Introduction to the Eyes
Relpax 12.2 Migraine Headaches and Migraine Headache Drugs
Remdesivir 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Remeron 13.1 Antidepressants
Remicade 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 40.3 Psoriatic Drugs
remission 10.1 Introduction to Myasthenia Gravis, 11.3 Introduction to Multiple Sclerosis
Renal calculi 33.1 Introduction to the Renal System
renal colic 33.1 Introduction to the Renal System
renal cortex 33.1 Introduction to the Renal System
renal medulla 33.1 Introduction to the Renal System
renal pelvis 33.1 Introduction to the Renal System
renal system Introduction
renin-angiotensin-aldosterone system (RAAS) 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 26.4 Glucocorticoids and Mineralocorticoids
Renin-angiotensin-aldosterone system (RAAS) 16.1 Introduction to the Heart, Circulation, and Blood Flow, 18.1 Hypertension and Angina
Repaglinide 28.3 Oral Antidiabetic Drugs
Repatha 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Requip 11.2 Anti-Parkinsonian Drugs
respiratory system Introduction
Restoril 13.2 Antipsychotics, 13.4 Anxiolytics and Sedative-Hypnotics
Retapamulin 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Retin-A 40.2 Acne Drugs
retinoids 40.3 Psoriatic Drugs
Reversible Acetylcholinesterase Inhibitors 10.2 Cholinergic Drugs
Reyataz 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Reye’s syndrome 14.2 Nonopioid Analgesics
Reyvow 12.2 Migraine Headaches and Migraine Headache Drugs
Rhinitis 23.1 Introduction to the Upper Respiratory System
rho kinase inhibitors 38.4 Antiglaucoma Drugs
Rhopressa 38.4 Antiglaucoma Drugs
Rifadin 7.5 Introduction to Tuberculosis and Antitubercular Drugs
Rifampin 7.5 Introduction to Tuberculosis and Antitubercular Drugs
Rifater 7.5 Introduction to Tuberculosis and Antitubercular Drugs
Rigidity 11.1 Introduction to Parkinson’s Disease
rimegepant 12.2 Migraine Headaches and Migraine Headache Drugs
Risedronate 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Risedronate sodium 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Risperdal 13.2 Antipsychotics, 13.2 Antipsychotics
risperidone 11.2 Anti-Parkinsonian Drugs , 13.2 Antipsychotics
Ritalin 13.5 CNS Stimulants and Nonstimulants
Rituxan 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 8.4 Biologic Response Modifiers
Rituximab 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs, 8.4 Biologic Response Modifiers
Rivaroxaban 20.2 Anticoagulants
Rivastigmine 10.4 Alzheimer’s Drugs
Rizatriptan 12.2 Migraine Headaches and Migraine Headache Drugs
Robitussin 24.2 Antitussives
Rocaltrol 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones
Rocephin 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Rods 38.1 Introduction to the Eyes
Rolaids 31.1 Antacids
Rolapitant 30.1 Antiemetics
ropinirole 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs , 13.2 Antipsychotics
Rosacea 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Rosuvastatin 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Rotarix 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
RotaTeq 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Rotigotine 11.2 Anti-Parkinsonian Drugs
Rotovirus vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
round down 2.4 Dosage Calculations
rounding off 2.4 Dosage Calculations
Rounding Rules 2.4 Dosage Calculations
Roxicodone 14.3 Opioid Agonists and Antagonists
rozanolixizumab-noli 10.2 Cholinergic Drugs
Rozerem 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics
Rust Belt 11.1 Introduction to Parkinson’s Disease
Rystiggo 10.2 Cholinergic Drugs
Rytary 11.2 Anti-Parkinsonian Drugs
Rythmol SR 17.2 Class I: Sodium Channel Blockers
S
sacubitril/valsartan 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Safinamide 11.2 Anti-Parkinsonian Drugs
Salagen 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs
Salex 40.2 Acne Drugs
Salicylates 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Salicylic acid 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 22.2 Cardiac Emergency Drugs, 40.2 Acne Drugs
Saline laxatives 30.3 Laxatives and Stool Softeners
saliva 29.1 Introduction to the Gastrointestinal System and Oral Cavity
saliva production stimulator 11.2 Anti-Parkinsonian Drugs
Salmeterol 25.1 Adrenergics and Anticholinergics
Salvage therapy 8.2 Chemotherapeutic Drugs
Samsca 26.3 Antidiuretic Hormones
Sandostatin 26.2 Growth Hormones and Suppressants, 30.2 Antidiarrheals
Savaysa 20.2 Anticoagulants
Saw palmetto 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Saxenda 32.4 Other Drugs, Supplements, and Herbal Remedies
Schedule I 1.3 Drug Classifications and Prototypes, 15.2 Opioid Use Disorder Drugs
Schedule II 1.3 Drug Classifications and Prototypes, 15.2 Opioid Use Disorder Drugs
Schedule III 1.3 Drug Classifications and Prototypes
Schedule IV 1.3 Drug Classifications and Prototypes
Schedule V 1.3 Drug Classifications and Prototypes
Schizophrenia in children 13.2 Antipsychotics
Scopolamine 30.1 Antiemetics
Scopolamine transdermal patch 30.1 Antiemetics
Seasonique 36.2 Hormonal, Contraception, and Infertility Drugs
sebum 40.2 Acne Drugs
second-generation antihistamines 24.1 Antihistamines and Decongestants
second-generation antipsychotics 13.2 Antipsychotics
Second-generation sulfonylureas 28.3 Oral Antidiabetic Drugs
secondary cancers 8.2 Chemotherapeutic Drugs, 8.2 Chemotherapeutic Drugs
secondary generalized seizures 12.1 Epilepsy and Anticonvulsant Drugs
sedative 13.2 Antipsychotics
sedative-hypnotics 13.4 Anxiolytics and Sedative-Hypnotics
seizure 12.1 Epilepsy and Anticonvulsant Drugs
Selective and irreversible MAO-B inhibitor 11.2 Anti-Parkinsonian Drugs
selective serotonin receptor agonists 12.2 Migraine Headaches and Migraine Headache Drugs
Selective serotonin reuptake inhibitors (SSRIs) 13.1 Antidepressants
selegiline 11.2 Anti-Parkinsonian Drugs , 13.1 Antidepressants
Semaglutide 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs, 32.4 Other Drugs, Supplements, and Herbal Remedies
semipermeable membrane 4.3 Maintaining Homeostasis
Senna 30.3 Laxatives and Stool Softeners
Senokot 30.3 Laxatives and Stool Softeners
sentinel event 3.2 Drug Errors and Prevention
Septra 35.1 Urinary Anti-infectives
Serdexmethylphenidate and dexmethylphenidate 13.5 CNS Stimulants and Nonstimulants
Serevent 25.1 Adrenergics and Anticholinergics
Seroquel 13.2 Antipsychotics
Serotonin 9.3 Characteristics of Drugs to Treat Nervous System Disorders
serotonin agonists 12.2 Migraine Headaches and Migraine Headache Drugs
serotonin deficiency 32.1 Introduction to Weight Management
serotonin norepinephrine reuptake inhibitors (SNRIs) 13.1 Antidepressants
serotonin syndrome 13.1 Antidepressants
Sertraline 13.1 Antidepressants, 13.1 Antidepressants
Serum albumin 33.2 Renal-Associated Fluid Volume Excess
Serum creatinine 34.1 Introduction to Diuretics
Serum osmolality 33.2 Renal-Associated Fluid Volume Excess
seven rights of medication administration 2.1 Drug Administration and the Nursing Process
sexually transmitted infections 36.2 Hormonal, Contraception, and Infertility Drugs
sexually transmitted infections (STIs) 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Shingrix 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
shock 5.1 Fluid Volume, 22.1 Introduction to Cardiac Emergencies and Shock
short-acting beta-2 agonist 25.1 Adrenergics and Anticholinergics
Short-acting insulin 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
side effects 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice , 2.2 Pharmacokinetics and Pharmacodynamics, 3.2 Drug Errors and Prevention
Sildenafil 36.7 Phosphodiesterase 5 Inhibitors
Silodosin 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Silvadene 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Silver sulfadiazine 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
simple focal seizures 12.1 Epilepsy and Anticonvulsant Drugs
Simvastatin 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors, 21.4 Cholesterol Absorption Inhibitors
Sinemet 11.2 Anti-Parkinsonian Drugs , 11.2 Anti-Parkinsonian Drugs
Singulair 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Sinus cavities 23.1 Introduction to the Upper Respiratory System
sinus tachycardia 17.1 Introduction to Dysrhythmias
Sinusitis 23.1 Introduction to the Upper Respiratory System
siponimod fumaric acid 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Sitagliptin 28.3 Oral Antidiabetic Drugs
Sitagliptin/metformin 28.3 Oral Antidiabetic Drugs
skin Introduction
Skyla 36.2 Hormonal, Contraception, and Infertility Drugs
sleep apnea 32.1 Introduction to Weight Management
sleep latency 13.4 Anxiolytics and Sedative-Hypnotics
sleep paralysis 13.5 CNS Stimulants and Nonstimulants
sliding scale coverage 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
small intestine 29.1 Introduction to the Gastrointestinal System and Oral Cavity
Social media 3.1 Legal Considerations
Socioeconomic factors 1.4 Special Considerations
Sodium 5.2 Electrolytes, 33.2 Renal-Associated Fluid Volume Excess
sodium and hydrogen antiporter 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
sodium bicarbonate 5.2 Electrolytes, 31.1 Antacids
Sodium channel blockers 17.1 Introduction to Dysrhythmias
Sodium oxylate 13.5 CNS Stimulants and Nonstimulants
sodium polystyrene sulfonate 5.2 Electrolytes
Sodium sulfacetamide 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
sodium-glucose cotransporter 2 inhibitor (SGLT2I) 19.4 Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2Is)
sodium-potassium-ATPase pump 5.2 Electrolytes
sodium–potassium–chloride (Na-K-2Cl or NKCC2) cotransporters 34.2 Loop Diuretics
Sofosbuvir 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
soft-stop alert 3.3 Documentation and Informatics
Solifenacin succinate 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics, 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Solriamfetol 13.5 CNS Stimulants and Nonstimulants
Solu-Cortef 26.4 Glucocorticoids and Mineralocorticoids
Solu-Medrol 26.4 Glucocorticoids and Mineralocorticoids
Solumedrol 25.2 Corticosteroids
solutes 4.1 What Is Homeostasis?
Somatic pain 14.1 Introduction to Pain
somatostatin analogs 26.2 Growth Hormones and Suppressants
Somatuline 26.2 Growth Hormones and Suppressants
Somavert 26.2 Growth Hormones and Suppressants
Sonata 13.4 Anxiolytics and Sedative-Hypnotics
Sorbitol 30.3 Laxatives and Stool Softeners
Sorine 17.4 Class III: Potassium Channel Blockers
Soritane 40.3 Psoriatic Drugs
Sotalol 17.1 Introduction to Dysrhythmias, 17.4 Class III: Potassium Channel Blockers
South Asian 32.1 Introduction to Weight Management
Sovaldi 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Sphingosine 1-phosphate (S1P) receptor modulators 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Spikevax 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Spinosad 7.6 Antiparasitic and Anthelminthic Drugs
Spiriva 25.1 Adrenergics and Anticholinergics
Spironolactone 18.6 Diuretics, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System, 34.4 Potassium-Sparing Diuretics
Spirulina 32.1 Introduction to Weight Management
squamous cell carcinomas 8.1 Introduction to Cancer and Phases of Cancer Therapy
St. John’s wort 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Stable angina 18.1 Hypertension and Angina, 22.1 Introduction to Cardiac Emergencies and Shock
Stalevo 11.2 Anti-Parkinsonian Drugs
stapes 39.1 Introduction to the Ears
Statins 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
steady state 10.4 Alzheimer’s Drugs
steatosis 32.1 Introduction to Weight Management
Stellara 40.3 Psoriatic Drugs
Stendra 36.7 Phosphodiesterase 5 Inhibitors
Sterapred 25.2 Corticosteroids
Stevens–Johnson syndrome 10.4 Alzheimer’s Drugs, 35.1 Urinary Anti-infectives
stigmatizing language 15.1 Introduction to Substance Use Disorders
Stimate 26.3 Antidiuretic Hormones
Stool softeners 30.3 Laxatives and Stool Softeners
Strattera 13.5 CNS Stimulants and Nonstimulants
stratum basale 40.1 Introduction to the Skin and Its Function
stratum corneum 40.1 Introduction to the Skin and Its Function
stratum granulosum 40.1 Introduction to the Skin and Its Function
stratum lucidum 40.1 Introduction to the Skin and Its Function
stratum spinosum 40.1 Introduction to the Skin and Its Function
stroke volume 18.1 Hypertension and Angina, 19.1 Heart Failure
StrongMed 16.3 Conduction of Electrical Impulses
stye 38.1 Introduction to the Eyes
subcutaneous 2.2 Pharmacokinetics and Pharmacodynamics, 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
subcutaneous injections 1.2 Drug Sources, Forms, and Names, 2.3 Drug Administration Routes, Preparation, and Administration
Sublimaze 14.3 Opioid Agonists and Antagonists
sublingual and buccal administration 2.3 Drug Administration Routes, Preparation, and Administration
Suboxone 15.2 Opioid Use Disorder Drugs
Substance Misuse and Dependence 12.1 Epilepsy and Anticonvulsant Drugs
substance P 14.1 Introduction to Pain
Substance use disorder 12.1 Epilepsy and Anticonvulsant Drugs , 15.1 Introduction to Substance Use Disorders
Subvenite 13.3 Mood Stabilizers
succimer 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Succinates 12.1 Epilepsy and Anticonvulsant Drugs
Sucralfate 31.3 Pepsin Inhibitors and Prostaglandin Analogues
Sudafed 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Sudafed PE 24.1 Antihistamines and Decongestants
Sulfamethoxazole and trimethoprim 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Sulfamylon 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Sulfasalazine 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Sulfonamides 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
sulfonylurea antidiabetic 13.2 Antipsychotics
Sulfonylureas 28.3 Oral Antidiabetic Drugs
Sumatriptan 12.2 Migraine Headaches and Migraine Headache Drugs
Sumaxin 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Sumycin 40.2 Acne Drugs
Sunday start method 36.2 Hormonal, Contraception, and Infertility Drugs
Sunosi 13.5 CNS Stimulants and Nonstimulants
superficial fascia 40.1 Introduction to the Skin and Its Function
Superinfections 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Supplemental oxygen 22.2 Cardiac Emergency Drugs, 23.2 Introduction to the Lower Respiratory System
Supplements 32.4 Other Drugs, Supplements, and Herbal Remedies
Suppositories 2.3 Drug Administration Routes, Preparation, and Administration
supraventricular tachycardia 17.1 Introduction to Dysrhythmias, 22.2 Cardiac Emergency Drugs
Surfak 30.3 Laxatives and Stool Softeners
Suvorexant 13.4 Anxiolytics and Sedative-Hypnotics
Swiss cheese model 3.2 Drug Errors and Prevention
Syeda 36.2 Hormonal, Contraception, and Infertility Drugs
sympathetic nervous system 9.2 Structure and Function of the Nervous System, Introduction
sympathomimetic 9.3 Characteristics of Drugs to Treat Nervous System Disorders, 25.1 Adrenergics and Anticholinergics
Symptomatic bradycardia 22.2 Cardiac Emergency Drugs
Symptoms of hypertension 18.1 Hypertension and Angina
synapse 9.3 Characteristics of Drugs to Treat Nervous System Disorders
syndrome of inappropriate antidiuretic hormone (SIADH) 26.3 Antidiuretic Hormones
synthetic drugs 1.2 Drug Sources, Forms, and Names
Synthetic interferons 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Synthroid 27.2 Thyroid and Antithyroid Drugs
Syphilis 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Systane 38.3 Ocular Anesthetics and Lubricants
systemic acne drugs 40.2 Acne Drugs
Systemic arterial pressure 16.1 Introduction to the Heart, Circulation, and Blood Flow
Systemic decongestants 24.1 Antihistamines and Decongestants
systemic psoriatic drugs 40.3 Psoriatic Drugs
systemic vascular resistance 16.1 Introduction to the Heart, Circulation, and Blood Flow, 22.1 Introduction to Cardiac Emergencies and Shock
systems of measurement 2.4 Dosage Calculations
systole 16.1 Introduction to the Heart, Circulation, and Blood Flow
systolic blood pressure 18.1 Hypertension and Angina
T
Tabloid 8.2 Chemotherapeutic Drugs
tachycardia 17.1 Introduction to Dysrhythmias
Tadalafil 35.5 Phosphodiesterase 5 Inhibitors, 36.7 Phosphodiesterase 5 Inhibitors
Tagamet HB 31.2 Histamine Blockers and Proton-Pump Inhibitors
Tamiflu 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Tamoxifen 8.3 Hormonal Therapy
Tamsulosin 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Tapazole 27.2 Thyroid and Antithyroid Drugs
Tarceva 8.4 Biologic Response Modifiers
tardive dyskinesia 11.1 Introduction to Parkinson’s Disease, 13.2 Antipsychotics
Targeted therapy 8.2 Chemotherapeutic Drugs
tartrate 12.2 Migraine Headaches and Migraine Headache Drugs
Tasmar 11.2 Anti-Parkinsonian Drugs
Taxanes 8.2 Chemotherapeutic Drugs
Taxol 8.2 Chemotherapeutic Drugs, 13.1 Antidepressants
Taxotere 8.2 Chemotherapeutic Drugs
Tazarotene 40.2 Acne Drugs, 40.3 Psoriatic Drugs
Tazorac 40.2 Acne Drugs, 40.3 Psoriatic Drugs
Taztia XT 17.5 Class IV: Calcium Channel Blockers
teaching plan 2.1 Drug Administration and the Nursing Process
Tecentriq 8.4 Biologic Response Modifiers
Tegretol 12.1 Epilepsy and Anticonvulsant Drugs , 13.3 Mood Stabilizers
Telmisartan 18.3 Angiotensin II Receptor Blockers (ARBs)
Temazepam 13.4 Anxiolytics and Sedative-Hypnotics
Tenecteplase 20.4 Thrombolytics
Tenex 13.4 Anxiolytics and Sedative-Hypnotics
Tenofovir 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Tenormin 17.3 Class II: Beta Adrenergic Blockers, 18.4 Beta-Adrenergic Blockers
teratogenic 1.2 Drug Sources, Forms, and Names, 1.4 Special Considerations, 36.3 Uterine Motility Drugs and Lactation Considerations
Terazosin 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
Teriflunomide 11.4 Drugs Used in the Treatment of Multiple Sclerosis
Tessalon 24.2 Antitussives
testicular reproductive system 36.5 Review of the Male Reproductive System
Testopel pellet 37.3 Masculinizing Hormonal Therapy
Testosterone 36.6 Androgens, Antiandrogens, and Anabolic Steroids
Testosterone cypionate 37.3 Masculinizing Hormonal Therapy
Testosterone enanthate 37.3 Masculinizing Hormonal Therapy
Testosterone gel 37.3 Masculinizing Hormonal Therapy
Testosterone patch 37.3 Masculinizing Hormonal Therapy
Testosterone undecanoate 37.3 Masculinizing Hormonal Therapy
tetany 31.1 Antacids
Tetracaine 38.3 Ocular Anesthetics and Lubricants
Tetracycline hydrochloride 40.2 Acne Drugs
tetracyclines 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 40.2 Acne Drugs
thalassemia 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Thalitone 18.6 Diuretics, 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
Theo-24 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Theobid 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Theophylline 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Therapeutic classification 1.3 Drug Classifications and Prototypes
Therapeutic effectiveness 2.1 Drug Administration and the Nursing Process
therapeutic effects 1.1 Pharmacology, Interdisciplinary Teams, and Nursing Practice
therapeutic index 2.2 Pharmacokinetics and Pharmacodynamics
Thermogenesis 32.1 Introduction to Weight Management
thermogenic foods 32.1 Introduction to Weight Management
thiazide and thiazide-like diuretics 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
Thiazolidinediones 28.3 Oral Antidiabetic Drugs
Thioguanine 8.2 Chemotherapeutic Drugs
third-generation antihistamines 24.1 Antihistamines and Decongestants
Thorazine 13.2 Antipsychotics
Thrombin 20.1 Introduction to Clotting and Coagulation
thrombocytes 8.2 Chemotherapeutic Drugs
Thrombocytopenia 8.2 Chemotherapeutic Drugs
Thrombolytics 20.2 Anticoagulants
thrombosis 20.1 Introduction to Clotting and Coagulation
Thromboxane A2 20.1 Introduction to Clotting and Coagulation
thyroglobulin 27.2 Thyroid and Antithyroid Drugs
Thyroid drugs 27.2 Thyroid and Antithyroid Drugs
thyroid gland 27.1 Introduction to the Thyroid and Parathyroid
Thyroid storm (thyrotoxic crisis) 27.1 Introduction to the Thyroid and Parathyroid
Thyroid-stimulating hormone 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus, 27.1 Introduction to the Thyroid and Parathyroid
Thyrosafe 27.2 Thyroid and Antithyroid Drugs, 27.2 Thyroid and Antithyroid Drugs
ThyroShield 27.2 Thyroid and Antithyroid Drugs
thyroxine (T4) 27.1 Introduction to the Thyroid and Parathyroid
Tiazac 17.5 Class IV: Calcium Channel Blockers
Ticagrelor 20.3 Antiplatelets
Tikosyn 17.4 Class III: Potassium Channel Blockers
Timolol hydrochloride 38.4 Antiglaucoma Drugs
Timoptic 38.4 Antiglaucoma Drugs
Tinnitus 39.1 Introduction to the Ears
Tiotropium 25.1 Adrenergics and Anticholinergics
Tirzepatide 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
titer 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
titrated 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Tivorbex 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
TNKase 20.4 Thrombolytics
tocolytics 36.3 Uterine Motility Drugs and Lactation Considerations
Tolcapone 11.2 Anti-Parkinsonian Drugs
tolerance 2.2 Pharmacokinetics and Pharmacodynamics, 14.3 Opioid Agonists and Antagonists, 15.1 Introduction to Substance Use Disorders
Tolterodine tartrate 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics, 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Tolvaptan 26.3 Antidiuretic Hormones
tonic-clonic seizures 12.1 Epilepsy and Anticonvulsant Drugs
tonicity 4.2 Osmolality
Topamax 12.1 Epilepsy and Anticonvulsant Drugs
Topical acne medications 40.2 Acne Drugs
topical anti-infectives 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Topical antibiotic 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
topical psoriatic drugs 40.3 Psoriatic Drugs
topical steroids 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Topiramate 12.1 Epilepsy and Anticonvulsant Drugs
Toprol XL 17.3 Class II: Beta Adrenergic Blockers, 19.3 Beta-Adrenergic Blockers
toremifene 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Torsade de pointes 17.1 Introduction to Dysrhythmias
Torsemide 19.5 Diuretics, 34.2 Loop Diuretics
Total cholesterol 21.1 Introduction to Lipoprotein and Apolipoproteins
Total parenteral nutrition (TPN) 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Touch therapy 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
toxicity 2.2 Pharmacokinetics and Pharmacodynamics
trabeculectomy 38.1 Introduction to the Eyes
train of four 10.2 Cholinergic Drugs
Tramadol 14.2 Nonopioid Analgesics
transaminase 31.2 Histamine Blockers and Proton-Pump Inhibitors
transcellular compartment 4.1 What Is Homeostasis?
Transcranial doppler 12.3 Intracranial Emergencies and Intracranial Emergency Drugs
Transderm-Scop 30.1 Antiemetics
Transdermal 2.3 Drug Administration Routes, Preparation, and Administration
transdermal patch 36.2 Hormonal, Contraception, and Infertility Drugs
Transduction 14.1 Introduction to Pain
Transfusion-associated circulatory overload 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products
Transgender 37.1 Overview of Transgender and Nonbinary Health
transient change 4.1 What Is Homeostasis?
transmission 14.1 Introduction to Pain
transsexual 37.1 Overview of Transgender and Nonbinary Health
Travatan 38.4 Antiglaucoma Drugs
Travoprost 0.004% solution 38.4 Antiglaucoma Drugs
Trazodone hydrochloride 13.1 Antidepressants
Tresiba 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Tretinoin 40.2 Acne Drugs
Trexall 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs, 8.2 Chemotherapeutic Drugs
Triamterene 18.6 Diuretics, 34.4 Potassium-Sparing Diuretics
Triazolam 13.4 Anxiolytics and Sedative-Hypnotics
trichomoniasis 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Tricor 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Tricyclic antidepressants (TCAs) 13.1 Antidepressants
trientine 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Trifluridine 38.2 Ocular Anti-inflammatories and Anti-infectives
Triglycerides 21.1 Introduction to Lipoprotein and Apolipoproteins, 21.1 Introduction to Lipoprotein and Apolipoproteins
Trihexyphenidyl hydrochloride 11.2 Anti-Parkinsonian Drugs
triiodothyronine (T3) 27.1 Introduction to the Thyroid and Parathyroid
Trimethoprim and sulfamethoxazole 35.1 Urinary Anti-infectives
trimethoprim and sulfamethoxazole (TMP/SMX) 35.1 Urinary Anti-infectives
Trimox 39.2 Otic Anti-inflammatories and Anti-infectives
Trintellix 13.1 Antidepressants
Triostat 27.2 Thyroid and Antithyroid Drugs
Triphasic COCs 36.2 Hormonal, Contraception, and Infertility Drugs
triptans 12.2 Migraine Headaches and Migraine Headache Drugs, 12.2 Migraine Headaches and Migraine Headache Drugs
Trokendi 12.1 Epilepsy and Anticonvulsant Drugs
trophoblasts 36.3 Uterine Motility Drugs and Lactation Considerations
Trosec 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Trospium chloride 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics, 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Trousseau sign 27.1 Introduction to the Thyroid and Parathyroid
Trusopt 38.4 Antiglaucoma Drugs
Tuberculosis (TB) 7.5 Introduction to Tuberculosis and Antitubercular Drugs
tubular necrosis 33.2 Renal-Associated Fluid Volume Excess
Tubuloglomerular Feedback 33.1 Introduction to the Renal System
Tumor lysis syndrome 8.1 Introduction to Cancer and Phases of Cancer Therapy
Tums 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 31.1 Antacids
Turmeric 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Tybost 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Tylenol 14.2 Nonopioid Analgesics
tympanic cavity 39.1 Introduction to the Ears
Type 1 diabetes 28.1 Introduction to Diabetes
Type 2 diabetes 28.1 Introduction to Diabetes
Tyrosine Factor/Growth Factor Inhibitors 8.4 Biologic Response Modifiers
Tysabri 11.4 Drugs Used in the Treatment of Multiple Sclerosis
U
U.S. Adopted Names Council 1.2 Drug Sources, Forms, and Names
U.S. Food and Drug Administration 2.1 Drug Administration and the Nursing Process, 28.1 Introduction to Diabetes
U.S. Pharmacopeia (USP) 3.1 Legal Considerations
Ublituximab (Briumvi) 11.3 Introduction to Multiple Sclerosis
Ulipristal acetate 36.2 Hormonal, Contraception, and Infertility Drugs
Ultram 14.2 Nonopioid Analgesics
ultraviolet (UV) light therapy 40.3 Psoriatic Drugs
United States Pharmacopeia National Formulary (USP-NF) 1.2 Drug Sources, Forms, and Names
Unstable angina 18.1 Hypertension and Angina, 22.1 Introduction to Cardiac Emergencies and Shock
upper esophageal sphincter 29.2 Introduction to the Esophagus and Stomach
Upper respiratory conditions 23.1 Introduction to the Upper Respiratory System
upper respiratory system 23.1 Introduction to the Upper Respiratory System
uric acid 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Urinary analgesics 35.3 Urinary Analgesics
urinary anti-infectives 35.1 Urinary Anti-infectives
Urinary incontinence (UI) 33.3 Introduction to the Urinary System
urinary retention 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Urinary stimulants 35.4 Urinary Stimulants
urinary tract infection (UTI) 33.3 Introduction to the Urinary System
Urine specific gravity 33.2 Renal-Associated Fluid Volume Excess
Urispas 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
Uroxatral 36.8 Alpha Blockers and 5-Alpha-Reductase Inhibitors
urticaria 24.1 Antihistamines and Decongestants
Ustekinumab 40.3 Psoriatic Drugs
Uterine contraction during childbirth 4.4 Negative Feedback Loop
Uterine motility drugs 36.3 Uterine Motility Drugs and Lactation Considerations
Uveitis 38.1 Introduction to the Eyes
V
Vaccine hesitancy 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Vaccine-preventable diseases 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations, 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Vaccines 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Vaccines and Immunizations 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Vagal maneuvers 17.1 Introduction to Dysrhythmias
Vaginal medications 2.3 Drug Administration Routes, Preparation, and Administration
vaginal ring 36.2 Hormonal, Contraception, and Infertility Drugs
Valerian 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Valium 12.1 Epilepsy and Anticonvulsant Drugs , 13.4 Anxiolytics and Sedative-Hypnotics
Valproates 12.1 Epilepsy and Anticonvulsant Drugs
valproic acid 12.1 Epilepsy and Anticonvulsant Drugs , 13.3 Mood Stabilizers
Valsartan 18.3 Angiotensin II Receptor Blockers (ARBs), 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Valtoco 12.1 Epilepsy and Anticonvulsant Drugs
Vancocin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Vancomycin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Vardenafil 36.7 Phosphodiesterase 5 Inhibitors
Varenicline 15.4 Nicotine Use Disorder Drugs
Variant (Prinzmetal) angina 18.1 Hypertension and Angina
Varicella vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Varivax 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Varubi 30.1 Antiemetics
vasa recta 33.1 Introduction to the Renal System
vasomotor response 35.4 Urinary Stimulants
Vasopressin 18.1 Hypertension and Angina, 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus, 26.3 Antidiuretic Hormones
Vasostrict 26.3 Antidiuretic Hormones
Vasotec 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Vaughan Williams classification system 17.1 Introduction to Dysrhythmias
veins 16.1 Introduction to the Heart, Circulation, and Blood Flow
Veklury 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Velban 8.2 Chemotherapeutic Drugs
Velcade 6.3 Immunosuppressants, Biologics, Monoclonal Antibodies, and Biosimilar Drugs
Venlafaxine 13.1 Antidepressants
Venous pressure 16.1 Introduction to the Heart, Circulation, and Blood Flow
Ventilation 23.3 Oxygenation and Gas Exchange
Ventolin 25.1 Adrenergics and Anticholinergics
ventricles 16.1 Introduction to the Heart, Circulation, and Blood Flow
ventricular diastole 16.2 Pumping Action of the Heart
Ventricular fibrillation 17.1 Introduction to Dysrhythmias, 22.2 Cardiac Emergency Drugs
ventricular tachycardia 17.1 Introduction to Dysrhythmias, 17.1 Introduction to Dysrhythmias, 22.2 Cardiac Emergency Drugs
ventrogluteal 2.3 Drug Administration Routes, Preparation, and Administration
Vepesid 8.2 Chemotherapeutic Drugs
Veracity 3.2 Drug Errors and Prevention
Verapamil 17.1 Introduction to Dysrhythmias, 17.5 Class IV: Calcium Channel Blockers, 18.5 Calcium Channel Blockers
Verelan 18.5 Calcium Channel Blockers
Verified Internet Pharmacy Practice Site (VIPPS) 1.2 Drug Sources, Forms, and Names
Very low-density lipoproteins (VLDL) 21.1 Introduction to Lipoprotein and Apolipoproteins
vesicant 8.2 Chemotherapeutic Drugs, 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Vesicare 35.2 Urinary Antispasmodics, Antimuscarinics, and Anticholinergics
vesicoureteral reflux 33.3 Introduction to the Urinary System
vestibular nerve 39.1 Introduction to the Ears
vestibulocochlear nerve 39.1 Introduction to the Ears
Viagra 36.7 Phosphodiesterase 5 Inhibitors
Vibramycin 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them, 40.2 Acne Drugs
Victoza 28.2 Insulin and Non-Insulin Injectable Diabetes Drugs
Viloxazine 13.5 CNS Stimulants and Nonstimulants
Vimpat 12.1 Epilepsy and Anticonvulsant Drugs
Vinblastine 8.2 Chemotherapeutic Drugs
Vincristine 8.2 Chemotherapeutic Drugs
viral load 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Virasal 40.2 Acne Drugs
Viread 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.3 Introduction to HIV, AIDS, and Antiretrovirals
virologic cure 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Viroptic 38.2 Ocular Anti-inflammatories and Anti-infectives
virulent 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
viruses 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Visceral pain 14.1 Introduction to Pain
Vistaril 30.1 Antiemetics
vitamin D 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 27.3 Calcium Preparations, Vitamin D, Bisphosphonates, Calcimimetics, and Peptide Hormones, 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Vitamin D3 conversion 33.1 Introduction to the Renal System
Vitamin K (Phytonadione) 20.2 Anticoagulants
Vitamins 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Vivitrol 14.3 Opioid Agonists and Antagonists, 15.2 Opioid Use Disorder Drugs
Voltaren 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Voltaren Ophthalmic 38.2 Ocular Anti-inflammatories and Anti-infectives
vomiting center (VC) 30.1 Antiemetics
von Willebrand factor 5.3 Intravenous Fluid Therapy, Total Parenteral Nutrition, and Blood Products, 20.1 Introduction to Clotting and Coagulation
Vortioxetine 13.1 Antidepressants
VP-16 8.2 Chemotherapeutic Drugs
Vraylar 13.2 Antipsychotics
Vytorin 21.4 Cholesterol Absorption Inhibitors
Vyvanse 13.5 CNS Stimulants and Nonstimulants
W
Wakix 13.5 CNS Stimulants and Nonstimulants
Warfarin 20.2 Anticoagulants, 20.2 Anticoagulants
Water-soluble vitamins 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
waveforms 16.3 Conduction of Electrical Impulses
Wegovy 32.4 Other Drugs, Supplements, and Herbal Remedies
weight bias 32.1 Introduction to Weight Management
Weight stigma 32.1 Introduction to Weight Management
Welchol 21.3 Bile Acid Sequestrants, Fibrates, and Niacin
Wet macular degeneration (WMD) 38.1 Introduction to the Eyes
White blood cells (leukocytes) 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
White clients 11.3 Introduction to Multiple Sclerosis, 13.1 Antidepressants, 28.1 Introduction to Diabetes
White petrolatum/mineral oil 38.3 Ocular Anesthetics and Lubricants
Wilms tumor/nephroblastoma 33.1 Introduction to the Renal System
Wilson’s disease 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
withdrawal 14.3 Opioid Agonists and Antagonists, 15.1 Introduction to Substance Use Disorders
women’s health 18.1 Hypertension and Angina
Women’s Health Initiative 37.2 Feminizing Hormonal Therapy
Wong–Baker FACES pain rating scale 14.1 Introduction to Pain
X
X-waiver 15.2 Opioid Use Disorder Drugs
Xadago 11.2 Anti-Parkinsonian Drugs
Xalatan 38.4 Antiglaucoma Drugs
Xanax 13.4 Anxiolytics and Sedative-Hypnotics, 13.4 Anxiolytics and Sedative-Hypnotics
Xanthines 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Xarelto 20.2 Anticoagulants
Xeloda 8.2 Chemotherapeutic Drugs
Xelstrym 13.5 CNS Stimulants and Nonstimulants
Xenical 32.3 Lipase Inhibitors
xerostomia 13.2 Antipsychotics
Ximino 40.2 Acne Drugs
Xopenex 25.1 Adrenergics and Anticholinergics
Xultrophy 28.3 Oral Antidiabetic Drugs
Xylocaine 17.2 Class I: Sodium Channel Blockers
Xyzal 24.1 Antihistamines and Decongestants
Y
Yanth 40.4 Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
Yasmin 36.2 Hormonal, Contraception, and Infertility Drugs
YAZ 36.2 Hormonal, Contraception, and Infertility Drugs
young adults 13.1 Antidepressants, 15.4 Nicotine Use Disorder Drugs
Z
Z-track method 2.3 Drug Administration Routes, Preparation, and Administration
Zafirlukast 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Zaleplon 13.4 Anxiolytics and Sedative-Hypnotics
Zaroxolyn 19.5 Diuretics, 34.5 Thiazide and Thiazide-Like Diuretics
Zebeta 19.3 Beta-Adrenergic Blockers
Zestril 13.2 Antipsychotics, 18.2 Angiotensin-Converting Enzyme (ACE) Inhibitors, 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Zetia 21.4 Cholesterol Absorption Inhibitors
Zileuton 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Zilxi 40.2 Acne Drugs
Ziprasidone 13.2 Antipsychotics
Zithromax 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 39.2 Otic Anti-inflammatories and Anti-infectives
Zocor 21.2 Statins (HMG-CoA Reductase Inhibitors) and PCSK9 Inhibitors
Zofran 30.1 Antiemetics
Zoledronic acid 36.4 Bisphosphonates, Calcium Preparations, Vitamin D, and Estrogen Receptor Modulators
Zollinger-Ellison syndrome 31.2 Histamine Blockers and Proton-Pump Inhibitors
Zolmitriptan 12.2 Migraine Headaches and Migraine Headache Drugs
Zoloft 13.1 Antidepressants
Zolpidem 13.4 Anxiolytics and Sedative-Hypnotics
Zomig 12.2 Migraine Headaches and Migraine Headache Drugs
zona fasciculate 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
zona glomerulosa 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
zona reticularis 26.1 Introduction to the Adrenal Cortex, Pituitary, and Hypothalamus
Zonegran 12.1 Epilepsy and Anticonvulsant Drugs
Zonisade 12.1 Epilepsy and Anticonvulsant Drugs
Zonisamide 12.1 Epilepsy and Anticonvulsant Drugs
Zoster vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
Zovirax 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs, 7.4 Introduction to Sexually Transmitted Infections and Drugs to Treat Them
Zyban 15.4 Nicotine Use Disorder Drugs
Zyflo 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Zyflo CR 25.3 Xanthines, Leukotriene Modifiers, and Mast Cell Stabilizers
Zyloprim 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
Zyprexa 13.1 Antidepressants, 13.2 Antipsychotics, 13.2 Antipsychotics
Zyrtec 13.2 Antipsychotics, 24.1 Antihistamines and Decongestants, 39.3 Otic Antihistamines, Decongestants, and Cerumenolytics
Zyvox 7.2 Antibiotic, Antiviral/Anti–COVID-19, and Antifungal Drugs
Previous
Order a print copy
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.